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Abstract 
This study examined the relationship between chronic pain and obesity, specifically examining 
the effects of obesity on multidisciplinary chronic pain treatment outcomes. Participants 
completed a 20-day intensive multidisciplinary chronic pain treatment program, and completed 
pre-post treatment measures assessing chronic pain. These measures were retrospectively 
analyzed to compare treatment response between obese and non-obese individuals. Mixed 
between-within ANOVA revealed that both obese and non-obese individuals responded 
dramatically to MCPM and there were no significant differences between groups on any of the 
provided measures. These findings suggest that even the most obese individuals benefitted 
significantly from MCPM, and suggest that chronic pain treatment may be a valuable precursor 
or adjunct to obesity and weight-loss treatment programs. 
Keywords: chronic pain, multidisciplinary chronic pain management, obesity 
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Introduction 
Chronic pain causes extensive damage in terms of public health, economic costs, and 
human suffering. The effects on an individual’s life of long-lasting pain that is not alleviated by 
drugs, surgery, or physical therapy can be ruinous, leading to depression, disability, and 
isolation. Individuals can become defined by fear and catastrophization, by their ongoing search 
for a cure, and by their perceived inability to cope with the basic elements of existence. Pain has 
been a primary focus of medical treatment since the advent of healthcare, and continues to be the 
number one reason people visit their physician, accounting for 70-80% of all doctor’s visits 
(Gatchel & Okifuji, 2006; Turk, 1996). Despite this, despite advances in understanding of pain 
mechanisms, and despite the development of advanced diagnosis and treatment, there remains no 
cure available that reliably and permanently eliminates pain for all patients (Turk). Biomedical 
approaches such as surgery and medications are often pursued relentlessly; unfortunately a 
significant portion of patients find that their pain has not been alleviated, but rather may have 
worsened. The distress of constant pain is often compounded by an accompanying hopelessness 
and demoralization brought about by a patient’s futile search for relief.  Because this wide range 
of psychosocial factors both contribute to and are consequences of chronic pain, comprehensive 
treatments focus on incorporating these in order to better address the full range of an individual’s 
suffering. While there may not yet be a cure for chronic pain, contemporary approaches focus on 
restoring emotional and physical functionality to an individual despite their persisting pain and 
disability.  
Multidisciplinary (or interdisciplinary) chronic pain management (MCPM) programs 
have become a popular treatment option for chronic pain because they provide cost-effective and 
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comprehensive care for treatment-refractory patients (Gatchel & Okifuji, 2006; Tunks, Weir, & 
Crook, 2008; Schatman, 2012; Turk & Burwinkle, 2005). MCPM was initially developed in 
response to the complexity of treating chronic pain, and is defined primarily as a rehabilitation 
program that incorporates multiple therapy modalities (Gatchel & Okifuji; Schatman). The focus 
within the most comprehensive of these is upon functional restoration, an intensive treatment 
approach that targets the physical deconditioning, chronic disability, pharmacological 
dependence, and the psychosocial and socioeconomic sequelae often associated with chronic 
pain. Patients are ideally taught methods to self-manage their pain rather than maintaining a 
focus on eliminating their pain. MCPM programs may offer important ways for patients to 
significantly improve their lives and general well-being. 
Numerous studies evaluating treatment outcomes of chronic pain management programs 
provide evidence that patients experience outcomes such as reduced pain intensity, improved 
mental health, increased functional tolerances, increased ability to self-manage pain, decreased 
life interference, decreased disability, improved health-related quality of life, and increased 
return to work (Flor, Fydrich, & Turk, 1992; Gatchel & Okifuji, 2006; Hoffman, Papas, 
Chatkoff, & Kerns, 2007; Morley, Eccleston, & Williams, 1999). However, a substantial 
proportion of patients do not appear to benefit equally from chronic pain management programs, 
as these studies also show significant variability in response to treatment and small to medium 
effect sizes (Thorn, Cross, & Walker, 2007; Turk & Rudy, 1990; Vlaeyen & Morley, 2005). 
Investigations of factors that predict treatment response have also produced inconsistent findings, 
as measuring and interpreting interaction effects between treatment and patient characteristics 
becomes exceedingly complex (McCracken & Turk, 2002; Turner, Holtzman, & Mancl, 2007). 
In a review of the literature, McCracken and Turk concluded that “no set of variables has been 
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shown to predict treatment outcome consistently,” (p. 2568) noting that results appear to depend 
on various patient characteristics, length of follow-up evaluation, and the particular outcome 
variable under study.  
However, it does not appear that treatment outcome studies have addressed a potentially 
moderating variable found frequently in chronic pain populations. Though previous findings 
(Burns, Johnson, Mahoney, Devine, & Pawl, 1998) indicated that physical and demographic 
characteristics of patients did not appear to influence treatment outcomes, Sellinger, Clark, 
Shulman, Rosenberger, Heapy, and Kerns (2010) determined that non-obese patients showed 
statistically significantly greater improvement following cognitive-behavioral treatment for 
chronic low-back pain than did their obese counterparts. Obesity occurs frequently with chronic 
pain and chronic pain is a prominent characteristic of obesity. Both obesity and chronic pain 
have been shown to be strongly associated with lower levels of emotional and physical well-
being and quality of life (Doll, Petersen, & Stewart-Brown, 2000). Despite this, the body mass 
index (BMI) of patients is rarely reported within pain literature (Sellinger et al.). Though there 
are examples in the literature noting the impact of chronic pain on the treatment for obesity, to 
date there are no other published studies that have compared the treatment outcomes of obese 
and non-obese chronic pain patients, and there have been no published studies comparing 
treatment outcomes of obese and non-obese patients specifically within a MCPM program.  
The function of a moderating variable is to affect the direction and strength of the 
relationship between variables; it specifies when and at what specific levels certain effects will 
occur; these conditions occur causally, at the same level as predictors, and are typically analyzed 
through ANOVA interaction (Vlaeyen & Morley, 2005). If obesity is a moderator, then it is an 
uncontrolled variable that may be affecting the strength of the relationship between treatment 
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and outcome and may account for variance in treatment outcomes. It may also indicate a patient 
characteristic that can addressed in order to better develop treatment interventions and target 
limited resources to those most likely to benefit (MacKinnon & Luecken, 2008). There has not 
been sufficient empirical evidence of obesity’s moderating effect on treatment to warrant its 
designation as an a priori moderator in an RCT of chronic pain treatment (Kraemer, Frank, & 
Kupfer, 2006), however an archival study may detect a treatment interaction effect, particularly 
with a relatively large sample size. 
About This Study 
The objective of this study was to see if treatment outcomes for obese patients differed 
from those of non-obese participants who completed a 20-day intensive MCPM program. A 
retrospective review of patient medical records from a multidisciplinary chronic pain treatment 
program was performed to determine if patients with a BMI of 30 and over (the standard cut-off 
measure of obesity used by the World Health Organization) showed different treatment outcomes 
than patients with a BMI of under 30.  In comparing the mean amount of change on each 
measure that non-obese patients make against the amount of change made by obese patients, this 
study expected to show that non-obese patients will show greater positive change (improvement) 
from pre- to post- treatment on measures of pain intensity, emotional distress, perceived 
disability, and pain-related fear and anxiety.  
The first goal was to evaluate the whether the effectiveness of the pain management 
program, as shown by significant improvement in patient functioning following treatment, varied 
according to whether a patient was classified as obese or non-obese. Although randomized, 
controlled trials are ideal for gauging treatment efficacy, previous studies have provided 
evidence of the overall effectiveness of MCPM programs, thus the non-randomized, non-control 
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group design based on archival records was determined to be sufficient to show a time effect 
attributed to treatment.  
The primary hypotheses were that patients who participated in and completed the 
treatment program would show statistically and clinically significant improvements in the 
domains of pain intensity, depression, pain related anxiety ability to self-manage pain, and 
perceived disability; the null hypothesis would be that participants showed no difference in test 
scores from pre- to post-treatment. Additionally, these improvements would vary according to 
whether the participants were classified as obese or non-obese. Finally, obese participants would 
show greater severity of impairment across treatment on self-report instruments of average pain 
intensity, emotional functioning, perceived disability, and self-efficacy.  
The second goal was to explore if obesity is associated with less improvement in 
response to multidisciplinary treatment. Thus second set of hypotheses stated that following 
treatment, obese chronic pain patients would show significantly less change on measures of pain 
intensity, disability, emotional distress, and ability to self-manage pain than non-obese chronic 
pain patients. The null hypothesis in this instance is there will be no statistically significant 
difference in average change scores on the measures when comparing obese patients to non-
obese patients.  
The following review of the literature will provide an overview of the problem, including 
the prevalence of chronic pain, the global economic and health impact of chronic pain, and the 
associated biopsychosocial sequelae. Further, I will also describe the phenomenon of chronic 
pain and how it is conceptualized by contemporary biopsychosocial pain models. Understanding 
the biopsychosocial conceptualization of pain is essential to understanding the rationale for 
multidisciplinary treatment of chronic pain. I will also provide a brief review of the extensive 
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literature on treatment outcomes and the role of the specific psychosocial variables measured in 
this study in chronic pain treatment. Lastly, I will consider the significant comorbidity between 
obesity and chronic pain, review their interdependent aspects, discuss the impact that obesity has 
upon treatment for other conditions, and discuss how these indicate its possible role within 
chronic pain management.  
Chronic Pain 
The International Association for the Study of Pain (IASP) states that “chronic pain is 
among the most disabling and costly afflictions in North America, Europe, and Australia” 
(2003).  It is believed the effects of chronic pain are likely similar in developing countries, 
though data is not available. The global prevalence of chronic pain is estimated to be 
approximately 20%. Based on a systematic review of 13 studies evaluating chronic pain in 20 
countries, with sample sizes ranging from 410 to 17,496, the IASP estimated the weighted mean 
prevalence of chronic pain in adult populations was 35.5%, with estimates ranging from 10.1% 
to 55.2%.  The data also indicated higher prevalence of CP among females and dramatically 
increased use of healthcare resources by CP patients. In 2011, the American Academy of Pain 
Management estimated that 100 million Americans suffer from chronic pain and their 
epidemiological studies estimated that 10 – 20% of the general North American population 
experiences chronic pain of over three months, with a lifetime rate of 29%.  It was also reported 
that 57% of adult Americans experienced recurrent or chronic pain in the past year, with 62% of 
these individuals reporting pain lasting over one year. Furthermore, individuals age 50 years and 
older were found to be twice as likely to be diagnosed with chronic pain, while there are 
approximately 35 million US residents 65 and older, and the proportion of the population aged 
65 is predicted to increase by 57% by 2030 (AAPM, 2011). 
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Thus, chronic pain is a pervasive and substantial problem for the American economy, 
directly affecting over 50 - 100 million Americans, costing over $70 billion annually in 
healthcare costs, lost productivity, tax revenue, and disability benefits, and accounting for more 
than 80% of all doctor visits (Gatchel & Okifuji, 2006; Turk, 1996). Moreover, these costs were 
usually compounded by the comorbid physical, functional, and/or psychiatric disorders found in 
about 87% of chronic pain patients. With 312 million prescriptions for analgesics written and 
317,000 lumbar surgeries performed each year, the medication and surgical costs add to the 
figure substantially (Gatchel & Okifuji). Similar findings for healthcare and economic costs have 
been found in the United Kingdom, The Netherlands, New Zealand, Australia, Denmark, 
Canada, Spain, and Italy (Gatchel & Okifuji).  
Pain itself is an adaptive response to bodily harm and is a natural result of injury or 
disease, and which likely abates with healing (Kerns, Sellinger, & Goodin, 2010). Chronic pain 
differs considerably from acute pain and should be understood as a complex interaction between 
physiological and psychosocial factors conceptualized within a biopsychosocial model (Engel, 
1977; Main & Spanswick, 2000). While acute pain sounds the alarm that alerts us to damage, 
chronic pain persists beyond the point of serving an adaptive purpose. Chronic pain can have a 
number of etiologies or related conditions including spinal injury or degradation, cancer, 
fibromyalgia, migraine headache, neuropathic injury, musculoskeletal injury, and rheumatoid 
arthritis. In some cases, however, the etiology is unknown or may have no objective 
pathophysiology. The correlation between objective physical findings that might be found on an 
MRI or X-ray and complaints of pain is often fairly low, with patients with severe pain 
demonstrating no objective evidence of injury while patients with abnormal findings on imaging 
tests will report little to no pain. This may be due to the limitations of current technology; 
EFFECTS OF OBESITY ON CHRONIC PAIN TREATMENT  
 
8
inflammation is difficult to detect though is a common factor in chronic pain. This may also be 
due to the fact that severe pain can develop secondary to systemic conditions such as diabetic 
neuropathy and nervous system dysfunction (Gatchel, Peng, Peters, Fuchs, & Turk, 2007).  
The IASP (2003) defines chronic pain as pain with little physiological purpose that has 
continued beyond expected appropriate healing time (suggested to be three months). Others have 
loosely defined chronic pain as any pain that lasts longer than six months (Gatchel et al., 2007). 
In many cases, chronic pain is diagnosed at the point where there is simply no longer an 
objective finding for its cause (Main & Spanswick, 2000). When an assessment focused solely 
on determining a physical cause for the pain is unable to do, the pain is often attributed to 
disordered psychology, perhaps resulting in diagnoses of malingering or somatoform disorder 
(Gatchel & Okifuji, 2006).  The effect of this is that, too often, frustrated physicians imply that a 
patient’s pain is imaginary. People with chronic pain often feel that they are put in the position of 
needing to express the degree of pain they are in, lest their suffering otherwise not be taken 
seriously. Moreover, individuals are often inadvertently reinforced for behavioral expressions of 
pain by solicitous coworkers and family members (Fordyce, 1976). Thus, even in terms of 
obtaining a diagnosis, psychological and social factors play a critical role in the subjective 
experience of chronic pain.   
There are a range of different pain syndromes that fall under the rubric of chronic pain, 
including musculoskeletal pain, myofascial pain and fibromyalgia; neuropathic pain such as 
complex regional pain syndrome, diabetic neuropathy, or neuritis; and different types of 
headaches and conditions such as cancer (Gatchel & Turk, 1996). And while there any many 
individuals in the US with chronic pain, most do not develop a complicated and problematic 
“chronic pain syndrome” that negatively impacts their functioning in a wide range of areas.  
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Many people are able to address elements of chronic pain through simple physical therapy or 
low-grade analgesics. However for a portion of patients, the following psychosocial sequelae 
begin to impact a significant portion of their daily existence, including: reduced activity, social 
withdrawal, poor sleep, depression, suicidal ideation, irritability, fatigue, memory deficits, and 
attention problems, damaged self-esteem, reduced libido, relationship difficulties, fear of 
movement, helplessness, hopelessness, substance abuse, guilt, anxiety, disability, employment 
and financial troubles, and low-self efficacy (US Dept. of Veterans Affairs, 2013).  Accordingly, 
these factors develop over time and contribute an important aspect to an individual’s suffering. 
These factors may pre-exist and predispose people to pain, acting as an antecedent to symptoms; 
they can diminish or amplify pain perceptions, be a consequence of chronic pain, and/or serve as 
maintaining factors (Gatchel et al., 2007).   
Thus, chronic pain causes significant changes in the familial, social, and physical roles of 
individuals, often creating years of suffering for many people. Most studies examining patient 
experience of chronic note that the subjective emotional experience inevitably tends to be quite 
negative (Gonzales, Martelli, & Baker, 2000).  Evidence shows that depression, anxiety, anger, 
fear, and hopelessness are prominent comorbid aspects of chronic pain that can serve to maintain 
or even amplify the degree of disability experienced by the individual (Gatchel, et al., 2007; 
Williams, Jacka, Pasco, Dodd, & Berk, 2006).  
It may be helpful to consider the development of chronic pain in an individual through 
the following scenario developed by Simon and Folen (2001):  
Often an injury, whether major or minor, causes the initial onset of pain, 
which leads to an initial decline in physical activity as part of early recovery. 
Lack of physical activity often causes ongoing muscle weakness and likely weight 
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gain, which can then aggravate muscles spasms, further exacerbating the chronic 
pain condition. As the limitations caused by the pain begin to take root, 
concomitant psychological issues may arise as the individual is forced to make 
undesired changes in work, family, and physical roles. The ongoing pain acts as a 
stressor, activating the sympathetic nervous system and thereby decreasing the 
individual’s pain threshold. Lack of medical progress, inability to work, disrupted 
family relationships, lack of exercise, and isolation all combine to increase 
anxiety and depression. Increased anxiety and depression often then serve to 
amplify the perception of pain. Moreover, pain and anxiety disrupt sleep patterns, 
causing both sleep onset and maintenance problems, often resulting in increased 
muscle tension, stress, depression, and anxiety. Individuals with severe chronic 
pain have been provided heavy doses of opiates, which may initially relieve the 
pain but can eventually increase pain sensitivity and intensify struggles with 
depression, anxiety, and anger. Anger and frustration continue to build as 
symptoms persist, the etiology of the pain remains unknown, and treatment 
failures accumulate. 
 
Considering this scenario, it is evident that chronic pain must be understood not only 
consider the biomechanisms underlying the pain, but through the cognitive, affective, behavioral, 
and social factors that further impact both the physical and psychosocial experience of pain. The 
phenomenon may best understood by comparing different theoretical models of pain, particularly 
the comprehensive biopsychosocial model.  
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Theoretical Models of Pain 
Historical theories of pain, such as Specificity Theory, presumed that pain always 
represents ongoing physiological injury and that the intensity is in exact proportion (isomorphic) 
to the amount of damage being sustained (Abram, 1993; Deardoff, 2003). Though this perception 
of pain existed since ancient Greece, French philosopher and mathematician Rene Descartes 
codified a mind/body duality in the 16th century that became the medical and philosophical 
heuristic of Western though for centuries. Since that time, the isomorphic model was been found 
overall to be an adequate heuristic for particular injuries and the immediate and short-term pain 
associated with them, and thus, provides the foundation for most medically-based pain 
interventions.  
The modern biomedical understanding of Specificity Theory proposes that special nerve 
fibers respond to stimuli such as pain, temperature, pressure, or location and transmit these 
signals (termed nociception) to the spinal cord and the brain (Siegele, 1974). There, the thalamus 
is stimulated, arousing the perception of pain, while the cerebral cortex interprets the impulses in 
terms of location and intensity. The cerebral cortex then sends descending nerve impulses that 
stimulate autonomic, musculoskeletal, and psychological responses. Analgesics are believed to 
depress the central nervous system at the thalamus and cerebral cortex, thus interrupting the 
perception and response to pain.  
Over time various limitations to this approach became evident through the observation of 
widely differential responses to injury and nociception, and the phenomenon of “phantom pain” 
in which an individual continues to experience pain in an amputated limb.  However, as late as 
the mid-20th century (and still today), chronic pain was conceptualized through a primarily 
biomedical approach focused on diagnosing and treating underlying pathology, with pain 
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considered to be in proportion to the severity of the assumed pathology. Treatment focused on 
identification of underlying pathology and its removal or treatment, which presumably would 
result in the elimination of pain. And if no specific pathophysiology was localized, then the pain 
was considered psychogenic (Vlaeyen & Morley, 2005).   
With the advent of Gate Control Theory (Melzack & Wall, 1965), there came a dramatic 
increase in research of the role of psychological moderators and mediators with pain. Gate 
control theory presented an alternative to traditional biomedical theories such as Specificity 
Theory, which did not provide explanation for or understanding of the influence of psychological 
factors on the perception of pain, idiosyncratic responses to injury, persisting pain beyond the 
expected recovery time, or phenomena such as phantom limb pain. Melzack and Wall integrated 
certain elements from earlier pain models while accounting for specific observations that had 
puzzled researchers and clinicians, specifically: 1) the variable relationship between injury and 
pain; 2) the observation that benign stimuli occasionally cause pain; 3) the inconsistent locations 
of pain related to injury; 4) the persistence of pain long past an injury’s healing; 5) the 
changeability of the experience of the pain and its location over time; 6) the multidimensional 
nature of pain; and 7) the lack of adequate chronic pain treatments (Gatchel et al., 2007). A 
significant change to the conceptualization of chronic pain took place once it was understood that 
pain was not simply the isomorphic representation of afferent nociception, but could be 
significantly altered by descending pathways (Vlaeyen & Morley, 2005). 
The distinctive aspect about Gate Control is the proposition that facilitatory neurons 
(“gates”) in the spinal cord, brain stem, or cerebral cortex can block or intensify the transmission 
route of a pain signal, resulting in altered pain perception (Deardoff, 2003; Siegele, 1974). 
Furthermore, the ability to modify the pain signal is greatly influenced by psychological factors 
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such as anxiety, fear, and depression. Gate Control proposes that the same mechanisms in the 
cerebral cortex that are responsible for sensory-discriminatory, motivational-affect, and cognitive 
processes also relay impulses that close or open the gates. 
Thus psychological factors can cause facilitatory interneurons on the transmission route 
to block the pain signal, resulting in little or no pain perception regardless of the amount of tissue 
damage occurring. Likewise, the same cells can intensify the pain stimulus along the route, 
resulting in far greater pain perception than warranted by the physical injury. Perhaps the 
theory’s most important contribution to the field is the way that it changed assumptions about 
pain perception, asserting that the introduction of central nervous system mechanisms that 
modulate the experience of pain meant that pain could never again be conceptualized as the sole 
product of peripheral input (Gatchel, et al., 2007). This proved to be a major advancement in 
pain research and treatment, though its explanatory value continues to be examined.  
Melzack (as cited in Gatchel et al., 2007) built upon Gate Control Theory with 
Neuromatrix theory, which served to provide further explanation for phenomena such as 
phantom limb pain and chronic pain. Neuromatrix theory proposes that pain is the consequence 
of an extensive “neural network” within the brain, rather than a isomorphic response to injury. 
The theory stipulates that the function of this distributed neural network (which Melzack termed 
the body-mind neuromatrix) is to activate sensory-perceptual, behavioral, and homeostatic 
systems in response to injury or stress. In an elegant arrangement of multiple constructs, Melzack 
proposed that chronic pain develops through a series of events following the original injury. In 
this model, ongoing pain creates a homeostatic imbalance, resulting in stress-induced triggering 
of the autonomic nervous system and eventual hypothalamic-pituitary-adrenal (HPA) axis 
dysregulation. Similar to the exhaustion phase of General Adaptation Syndrome (Selye, 1950), 
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consequences of ongoing stress will include eventual muscle atrophy, impaired tissue repair, and 
immune system suppression (Gatchel et al.). Thus, the biological and psychological sequelae of 
chronic pain, serve to reinforce and sustain pain perception and physical deconditioning, thus 
contributing to the chronicity of the condition in an positive feedback loop.  
Interestingly, contemporary neuroscience and genetic research has substantiated much of 
this conceptualization, providing evidence that genetic factors, neurotransmitters, and hormones 
play a crucial role in the development and maintenance of chronic pain (Gatchel et al., 2007). 
Thus, Neuromatrix theory continued the trend of shifting the focus of pain research away from 
sensory mechanisms and towards cognitive, emotional, and behavioral factors capable of 
producing experiences in the body. 
Melzack and Casey (1969) expanded understanding of the role of emotion by proposing 
that emotional distress is concomitant with nociception rather than its consequence, further 
integrating the objective physical nociception (“pain”) and subjective emotional experience of 
pain (“suffering”). This increased understanding of the emotional pain concomitant with 
nociception has provided insight into a critical area for patient care.  Gate Control Theory, 
considered in the context of the Biopsychosocial model of health (Engel, 1977), led to the 
development of Biopsychosocial models of pain built around the idea that the experience of pain 
was not only the product of nociception, but also an individual’s subjective cognitions, affect, 
behavior, and environment. Key to the model is the realization that the numerous 
biopsychosocial sequelae of chronic pain are capable of creating a positive feedback loop, with 
consequences serving as maintaining and aggravating factors (Gatchel, et al., 2007). Thus, the 
Biopsychosocial model of pain provides a more sophisticated understanding of the complex role 
that stress and mood play in the perception of pain, and made explicit a comprehensive paradigm 
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that shows how cognition, behavior, and environment specifically interact with physiology to 
generate, aggravate, and maintain chronic pain. These comprehensive and multidimensional 
understandings of chronic pain have largely replaced the simpler biomedical models and have 
generated a wealth of research (Kerns et al., 2011). The Biopsychosocial model also made way 
for a wide range of intervention avenues for patients whose pain had otherwise been treatment 
refractory and forms the basis for multidisciplinary treatment of chronic pain (Kerns et al.,).  
 
The Role of Psychological Factors in the Experience of Chronic Pain 
Perception of Pain Intensity 
As noted, the nature or severity of an injury does not reliably predict the perception of 
pain or the suffering endured. The premise of gate control theory is that the pain signal 
(nociception) can be potentially modulated, blocked, or enhanced, by chemical “gates” that are 
responsive to stress, anger,  and depression, and even the meaning of the pain. Patients’ 
understanding of their condition and their expectancies for relief, their self-concept, their self-
efficacy, and the medico-legal system impacts their perceptions and reports of pain (Tumlin, 
2001).  By addressing the domains that affect the “gates” through cognitive behavioral 
interventions, patients’ perceptions and experience of pain may change significantly.  Patients 
may experience unchanged pain intensity levels, in fact, but report reduced life interference, 
depression, disability, and fear.   
Depression 
Psychological factors have a direct impact on chronic pain patients’ quality of life and 
disability (Turk & Okifuji, 2002). Epidemiological studies have identified specific psychological 
factors that are now recommended to be an important aspect in the experience and treatment of 
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chronic pain.  Depression is one of these primary factors as it interferes with a person’s ability to 
cope with pain, and negatively impacts motivation and self-efficacy (Gatchel, et al., 2007). There 
is a great deal of overlap between the somatic and cognitive symptoms of depression and chronic 
pain (and indeed, many chronic health conditions) including attention and concentration 
impairment, weight changes, psychomotor agitation or retardation, sleep problems, changes in 
appetite, fatigue, and difficulty functioning. Changes in occupational and familial roles can lead 
to feelings of worthlessness, helplessness, and guilt.  
Depression is so prevalent within chronic pain populations, that a meta-analysis of 83 
studies (Fishbain, Cutler, Rosomoff H., & Rosomoff R., 1997) examined whether depression is 
an antecedent or consequence of chronic pain. The authors found 5 common hypotheses: 1) 
depression precedes the development of pain (“antecedent”); 2) depression follows the 
development of chronic pain (“consequence”); 3) some patients have a genetic predisposition to 
depression, and within the context of chronic pain, become depressed (“scar hypothesis”); 4) 
either antecedent or concomitant psychological mediators such as life interference or poor self-
efficacy mediate a relationship between pain and depression (“cognitive behavioral mediation 
model”); and 5) depression and pain share a common pathogenetic / neurochemical mechanism.  
The results of the study did not present a clear answer, but there was far greater evidence for the 
consequence and scar hypotheses, particularly as some studies were able to specify the direction 
of the effect.  
Pain Related Anxiety 
Several studies have demonstrated a relationship between pain-related anxiety and pain-
related impairment. The construct of pain anxiety is comprised of racing thoughts and impaired 
concentration related to pain, fearful cognitions and negative expectancies due to pain, overt 
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harm-avoidance behaviors intended to minimize pain, and physiological responses to pain 
(McCracken & Gross, 1992). Pain-related catastrophizing is a primary element of this domain, 
and is defined as a “negative cognitive-affective response in pain…characterized by the tendency 
to magnify and predict the worst concerning a particular experience of pain” (Sharpe, 2012, p. 
951).  Catastrophizing has been found to play a significant role in the development and 
maintenance of chronic pain, and seems to predict a number of treatment outcomes including 
depression, disability, return to work, and healthcare utilization (Sharpe; Turk & Okifuji, 2002). 
Changes in pain related anxiety are highly associated with, and may be more predictive of, 
positive treatment outcomes independent of physical capacity performance (McCracken & 
Gross).  
Pain-related anxiety is also characterized by a fear of movement (kinesiophobia) and 
avoidance. Fear avoidance is primarily manifested in catastrophic thoughts related to pain and 
future possible injury, in addition to over-awareness of physical sensations and symptoms (Kerns 
et al., 2011). One study evaluating pain patients, found that those who reported greater pain-
related fear-avoidance (as measured by the Pain Anxiety Symptoms Scale) over-predicted the 
intensity of pain related to an unfamiliar movement while those who reported less pain related 
anxiety, under predicted pain; further, greater pain anxiety was related to less range of motion 
overall regardless of actual pain levels reported (McCracken & Gross, 1993).  Results also 
indicated that patients with greater levels of cognitive anxiety related to pain were far more 
likely to report less ability to control or decrease their pain, and far less likely to demonstrate 
adequate pain coping skills.  
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Self-Efficacy 
The construct of self-efficacy, defined as the belief in one’s ability to perform certain 
required behaviors in a specific situation, has become an important factor in chronic pain 
management. Self-efficacy theory (Bandura, 1977) proposed that if a person has enough 
motivation to perform a behavior, then it depends on the person’s self-efficacy beliefs whether 
that behavior is initiated, how much effort is expended, and the degree to which effort is 
expended and maintained when the behavior is challenged or blocked. Patients with low self-
efficacy are more likely to give up or return to old behaviors when challenged that those with 
high self efficacy. In the context of chronic pain management and functional restoration,  the 
foundational aspects of coping and self-management behaviors are mediated by a patient’s self-
efficacy (Turk & Okifuji, 2002).  Numerous studies (as cited by Turk & Okifuji), have shown 
that self-efficacy is strongly related to pain control, healthy emotional functioning, perceived 
disability, impairment, physical task levels, increase in exercise, medication use, treatment 
outcomes, and return to work.  
The role of self-efficacy in chronic pain cannot be understated. Self-efficacy as a focus of 
chronic pain treatment is important because so much of treatment is related to ongoing “self-
management” of pain. Pain management patients are expected to make significant behavioral and 
lifestyle changes including reducing stress, increasing physical activity, improving pacing, 
improving nutrition, and increasing engagement in valued activities despite ongoing nociception. 
Pain-related self-efficacy beliefs have been shown to be strong predictors of pain severity, 
interference, and general activity, accounting for up to 45% of the variance in one treatment 
outcome regression model (Strong, Westbury, Smith, McKenzie, & Ryan, 2002).  
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Perceived Disability 
The American Medical Association defines disability as a change in a person’s capacity 
to meet social, familial, occupational, and personal demands because impairment resulting from 
loss of function (as cited in Shoefferman, 2006). Psychosocial factors including perception of 
disability, inadequate social support, increased psychological distress, job dissatisfaction, 
workers’ compensation, and occurrence of pain behaviors appear to be more significant 
predictors of long-term chronic disability than severity of injury or job description (Turk & 
Okifuji, 2002). Within chronic pain populations, the perception of disability can be the logical 
outcome resulting from months or years of severe pain, depression, fear, anxiety, and a perceived 
lack of control over one’s life and ability to manage. Furthermore, a significant diminishment in 
functionality accompanies years or months of inactivity, including cardiorespiratory 
deconditioning, decreased muscle strength, and decreased flexibility (Schoefferman). Perceived 
disability is exacerbated by avoidance behaviors and catastrophic cognitions related to fear of 
increased pain related to activity, a misapprehension that activity will result in further injury, and 
the perception that severity of pain is a direct reflection of severity of injury. Importantly, 
patients who are able reduce depression, catastrophization, fear of movement, and improve self-
efficacy in treatment have better outcomes, uniquely predicting improvements in disability 
(Bergbom, Boersma, & Linton, 2012).  
Treatment of Chronic Pain 
 Biomedical treatment 
“Successful treatment of chronic pain produces a patient who describes the pain in mild 
terms, engages in productive and satisfying activity on a daily basis, is free of excess emotional 
suffering, and uses medical resources at a prudent level” (McCracken & Turk, 2002). 
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One can see from the previously described psychosocial sequelae why traditional 
biomedical treatment might be insufficient to treat many chronic pain patients, with no individual 
medication, procedure, or treatment able to address the multiple dimensions, symptoms, and 
consequences of the condition (Gatchel & Okifuji, 2006). Traditional medical interventions for 
chronic pain focus on identification of the specific cause underlying a symptom, followed by 
treatment to surgically remove the pathology, or block the pain with medication or an 
implantable device. Specific single modality interventions include ablative techniques, 
acupuncture, nerve blocks, joint blocks, epidural steroid injection, intrathecal non-opioid 
injections, and botulinum toxin injections; electrical nerve stimulation interventions include 
subcutaneous peripheral nerve stimulation, spinal cord stimulation, and transcutaneous electrical 
nerve stimulation (TENS); minimally invasive spinal procedures include vertebroplasty, 
kyphoplasty, and percutaneous disc decompression (American Society of Anesthesiologists, 
2010).  These solutions address the needs of a significant proportion of the chronic pain 
population. However they can often prove to be ineffective if not injurious, such as in failed back 
surgery syndrome, and most of the time they are extremely expensive (Gatchel & Okifuji). There 
are about 300,000 to 400,000 spine surgeries performed each year, with success rates (defined as 
a reduction in pain and medication use and  improvement in functional ability) measuring from 
50-90% depending on the type of surgery (Gatchel, 2001). This approach implies there is a cure 
for the pain, and patients will often agree to multiple treatments, surgeries, and medications in 
search of this (Gatchel & Okifuji). Often the “allure of the cure” motivates a client to pursue one 
failed surgery or injection after another rather than focusing on acceptance and rehabilitation. 
(Clarke & Iphofen, 2007; DeGood & Tait, 2001; Geisser, 2006). 
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Unfortunately, patients often embrace the biomedical model of pain and pursue treatment 
determined to prove the validity of their chronic pain and the extent of their suffering, rather than 
exploring untried treatment options, and this fundamental misunderstanding of chronic pain 
management often leads to noncompliance or failure (DeGood & Tait, 2001). Chronic pain 
patients are often more likely than controls to attribute the degree of pain experienced to physical 
rather than psychological mechanisms (Allcock, Elkan, & Williams, 2007). Self-management 
strategies are often regarded with utter disbelief and skepticism, and treatment options such as 
psychotherapy, biofeedback, and relaxation training appear to imply that the pain is “all in their 
head,” and therefore not real (Clarke & Iphofen, 2007).  
Lastly, traditional biomedical treatment models seek to match an intervention to the 
medical diagnosis. While this is effective when the symptoms have a known etiology, it is often 
not appropriate for diagnoses whose cause is unknown which is frequently the case with chronic 
pain (Turk & Okifuji, 1998). For instance, Waddell asserted that only 15% of patients with low 
back pain are given a specific medical diagnosis (as cited in Wittink, Nicholas, Kralik, & 
Verbunt, 2008). However, even when a diagnosis can be made, there is often a sharp discrepancy 
between the severity of the objective findings and the level of patient disability.  
Opioids are a standard treatment option in the management of pain (Tunks, Weir, & 
Crook, 2008), though the side effects, the potential for abuse, and the complexity in managing 
tolerance of the analgesic effect makes them a less-than-optimal choice for managing chronic 
pain (Gatchel et al., 2007).  Patients report that opioids lose their effectiveness over time (due to 
habituation), and require increasingly large doses; with these increasing doses, side-effects such 
as cognitive impairment and gastro-intestinal issues worsen. The possibility of pain-killer abuse 
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and dependence cannot be discounted, particularly in patients that are not followed closely by 
pain management specialists.  
Other options for pharmacological management for chronic pain include anti-depressants, 
anticonvulsants, benzodiazepines, NMDA receptor antagonists, nonsteroidal antiinflamatory 
drugs (NSAIDs), skeletal muscle relaxants, and topical agents, all of which have also been 
shown to be helpful in treating several chronic pain conditions, including migraines, 
fibromyalgia, and neuropathic pain (American Society of Anesthesiologists, 2010). Importantly, 
however, one qualitative study with chronic pain patients revealed that many patients do not 
consider pain medications to be treatment but rather a way of being “fobbed off” (Allcock et al., 
2007). To that end, frequently patients are simply provided ongoing medication rather than 
specific treatment for chronic pain.   
Due to its nature, chronic pain is best assessed and treated within the broader context of 
illness, rather than as a disease (though there are efforts to have chronic pain considered a 
disease in its own right). The distinction between disease and illness lies in the difference 
between an objective anatomical and physical pathology (disease), while illness encapsulates the 
subjective experience being sick and how patients and families respond to and cope with 
symptoms (Gatchel et al., 2007). Thus, like other chronic health conditions, the focus of 
treatment shifts to symptom management rather than a search for a cure (Main & Spanswick, 
2000).  
Chronic Pain Management 
Chronic pain management diverges from the biomedical focus on underlying diagnosis to 
the impact of the illness on activities of daily living, and strives to identify the behavioral factors 
that may be operating to aggravate and maintain pain. As standard medical care often provided 
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inadequate treatment for chronic pain, psychology researchers and clinicians increasingly 
focused on cognitive-behavioral assessment and  intervention, concentrating on rehabilitation 
and behavior-change rather than a cure (McCracken & Turk, 2002).  Chronic pain management 
goals are a function of the numerous stakeholders involved, and include everything from return 
to work and decreased healthcare utilization, to pain relief and improved daily functioning 
(Gatchel & Okifuji, 2006).  The psychosocial targets of treatment address the multiple domains 
of a patient’s life and can include medication, functionality, depression, fear-avoidance, anxiety, 
anger, disordered sleep, isolation, disrupted familial and interpersonal relationships, substance 
abuse, and other comorbid conditions (Adams, Poole, & Richardson, 2006; Fillingim, 1997; 
McCracken & Gross, 2002; Kerns et al., 2011; Simon & Folen, 2001).  
Comprehensive assessments gather information about the impact that chronic pain has 
had upon the patient’s activities of daily living, hobbies, work, and family relationships. The 
implication is that these various areas have been impacted by chronic pain, and that to adequately 
self-manage the condition, patients will need to develop ways to make improvements in all these 
areas. By gathering valid and reliable measurements of the patient’s level of disability, the daily 
amount of physical activity, and the ways that “pain behaviors” (Fordyce, 1977) and 
psychopathology are functioning as barrier to recovery, these psychological and behavioral 
factors serve as the focus for treatment in order to decrease the impact that pain has upon a 
person’s ability to function. (Wittink et al., 2008). These assessments primarily use self-report 
instruments that evaluate pain-related psychological status, social and environmental stressors, 
pain-related disability, fear of pain, readiness to adopt self-management strategies, belief in 
ability to manage pain, types of coping skills, and pain related attitudes. (Bradley & McKendree-
Smith, 2001).   
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Physical evaluation of chronic pain often includes a quantified assessment of the 
functional capacity of affected areas such as the lumbar spine (Polatin & Mayer, 2001).  
Measures such as range of motion, trunk strength, lift/carry capacity, and cardiovascular 
endurance introduce a degree of objectivity into chronic pain assessment, and are a useful way to 
measure changes from baseline at the beginning of rehabilitation. These measures are also 
commonly used to assess for disability compensation because of the self-report assessment 
limitations that are characteristic of chronic pain. 
The physical and medical modalities of chronic pain management include medication 
management, exercise, heat, cold, massage, transcutaneous electrical nerve stimulations (TENS), 
and assistive devices. Furthermore, chronic pain patients are often characterized by patterns of 
pain coping that have emphasized an overly sedentary and avoidant lifestyle. This is addressed 
by the activity and physical therapy aspects of treatment as these patients are often very de-
conditioned and weak;  this emphasis on activity and reinforcement for adoption of healthy 
behaviors has been shown to be predictive of reduced disability and improved emotional 
functioning (Keefe, Williams, & Smith, 2001). There is limited but positive evidence that 
physical modalities are effective at managing chronic pain, with the greatest support found for 
therapeutic exercise (Rakel & Barr, 2003). Not surprisingly, certain traits may decrease 
effectiveness of physical modalities, including obesity, depression, anxiety, and narcotic use, so 
they may best be incorporated into comprehensive programs that can address these issues. 
However, Rakel and Barr note that most studies published in medical or physical therapy 
journals primarily focus on physical modalities as a monotherapy rather than as an adjunct to 
comprehensive treatment, so little is known about their role in MCPM. 
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Psychological treatment of chronic pain 
While Gate control and Neuromatrix theory theories provide insight into the physical and 
emotional structures of the biopsychosocial model of pain, much of contemporary understanding 
of pain’s psychosocial aspects has been built upon behavioral conceptions of chronic pain and 
illness (Fordyce, 1976; Patterson, 2005).  An important development in the evolution of chronic 
pain treatment came when Fordyce proposed that environmental contingencies and rewards 
contributed to the maintenance of pain and pain behaviors (overt signs of pain and suffering), 
while still emphasizing the true suffering experienced by patients. After Gate-control theory, this 
was the first major advancement in the psychological treatment of chronic pain and  it focused on 
identifying and targeting operant conditioning factors that served to maintain pain behaviors such 
as excessive dependence on bed rest, overly solicitous family members, over reliance on 
medications, and an overall lack of activity.  The rationale for this approach recognized that pain 
behaviors could transition over time from physical/biomechanical reinforcement to functional/ 
environmental and by reinforcing “well behaviors,” patients could begin to regain their 
independence and functionality. Additionally, sufficient physical “evidence” for pain did not 
negate the likelihood that psychosocial factors mediated the experience of disability associated 
with pain (Vlaeyen & Morley, 2005). Fordyce described pain behavior as the overt behaviors 
that people demonstrate when they are suffering, noting that responses to suffering necessarily 
involved the interpretive function of the brain. He reasoned that reactions to nociception were 
filtered through expectancies, previous experiences, and anticipated consequences (Fordyce, 
1988). Rather than a simple reflexive response, pain behaviors “occur as the complex end-
product of the synthesis of signals from various sensory modalities to the central nervous system 
with other information in the brain” (Fordyce, 1988, p. 279).  
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Thus, pain behaviors, though indicative of suffering, reveal little about the actual degree 
of nociception. Fordyce (1976) identified that the acquisition of these behaviors was subject to 
the same operant processes as other learned behaviors, and that by controlling rewards and 
contingencies, treatment could perhaps alleviate significant levels of suffering and disability 
(Patterson, 2005). These contingencies often consist of the unpleasant activities that a patient is 
able to avoid, such as household chores, or rewards such as disability payments, or solicitous 
attention from a spouse (Patterson). By identifying environmental and interpersonal reinforcers, 
an rich area for treatment was developed that emphasized behavioral treatments focused initially 
on the identification and modification of environmental contingencies that might be operating to 
maintain pain behaviors.  
Patients’ beliefs about their pain have also been shown to have a significant impact upon 
treatment outcomes, particularly when a patient is focused on finding an organic cause to their 
pain or is intent on curing the condition rather than managing it (Allcock et al., 2007). Cognitive 
factors including a perception of pain as uncontrollable, mysterious, and enduring or a perception 
of pain as necessarily creating disability have been associated with increased depression and 
disability, and poorer treatment compliance and outcomes. (Allcock et al.; Turk & Okifuji, 
1996).  One study examining mediators of change in CBT for chronic pain found that pre- to 
post-treatment changes in patient pain-related beliefs, including reduced catastrophizing, 
increased perceived ability to control pain, and decreased belief that one is disabled by pain were 
significantly related to reduced pain intensity and activity interference (Turner, Holtzman, & 
Mancl, 2007).  
Thus, cognitive-behavioral therapy (CBT) provides the crux of most psychological 
interventions with chronic pain. The four general types of psychological intervention that have 
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received the most research support are self-regulatory, behavioral, cognitive-behavioral, and 
acceptance and commitment therapies (Kerns et al., 2011). Self-regulatory approaches are 
focused on increasing a patient’s sense of control over physical and psychological experiences. 
The primary interventions in this approach include biofeedback, relaxation training, clinical 
hypnosis, and mindfulness (Kabat-Zinn, 1982). Biofeedback studies have shown it to be an 
effective intervention for chronic headache, with clinical effects lasting for over a year past 
treatment (Kerns et al.; Nestoriuc et al. 2008). These lasting effects are possibly related to the 
emphasis placed on the patients learning to voluntarily control physiological processes. 
Relaxation training also focuses on patients learning to identify states of tension and 
systematically reduce perception of pain and physiological arousal through methods such as deep 
breathing, progressive muscle relaxation, or visualization (Kerns et al., 2011). There is a 
significant psychoeducation component to relaxation training so that patients can begin to 
understand the link between autonomic system arousal and emotional/physiological states. 
Studies have shown it to be effective for musculoskeletal pain, headache, and back pain (Kabat-
Zinn, 1982; Kerns et al.; 1991; Strong et al. 1989). Mindfulness meditation is gaining wide 
acceptance as a  treatment for refractory chronic pain, particularly due to the efforts of Jon 
Kabat-Zinn, whose work has shown this to be effective in reducing pain intensity, increasing 
physical activity, and increasing adaptive emotional functioning.  
Behavioral approaches, as previously discussed, focus primarily on pain behaviors and 
their reinforcers. These approaches include operant behavioral therapy interventions for family 
and friends who often unknowingly reinforce the verbal or resting behaviors that contribute to 
disuse syndrome. Reviews of these operant behavioral interventions show increased activity 
levels, decreased disability, and improved quality of life above and beyond that accomplished 
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through more comprehensive treatment (Kerns et al., 2011). Exposure behavioral techniques 
have also been directed towards the fear of movement and avoidant behaviors so commonly seen 
in patients, and which have shown to be predictive of future disability (Asenlof, 2010; Crombez, 
Vlaeyen, Heuts, & Lysens, 1999; Vlaeyen, 2000). In vivo exposure has been shown to have a 
significant effect on fear avoidance behaviors, helping patients engage in physical activities 
while decreasing their fears of further injury (Woods & Asmundson, 2008).  
The three primary elements of CBT for pain is psychoeducation to help the patient better 
understand the role that cognitions and behavior play in the pain experience, the introduction of 
active coping skills training such as progressive muscle relaxation, pacing, and distraction 
techniques, and cognitive restructuring to identify and challenge overly negativistic or 
catastrophic thoughts related to pain (Kerns et al., 2011).  Cognitive treatment emphasizes the 
role that thoughts and beliefs take in attending to physical sensations and emotional and 
behavioral responses (Vlaeyen & Morley, 2005). Targeted cognitions such as catastrophizing, 
low pain self-efficacy, and external locus of control have been identified as mediators of 
treatment outcomes.  Lastly, CBT programs emphasize the role that autonomic arousal and 
muscle tension play in the etiology and maintenance of pain.  Incorporating biofeedback and 
relaxation skills (including mindfulness meditation) is often a key element of MCPM programs. 
(Vlaeyen & Morley). 
Common components of both behavioral and CBT treatments include promotion of a 
self-management perspective; relaxation skills training; cognitive restructuring; behavioral 
activation including pacing strategies; problem-solving skills training; attentional control 
strategies; communication skills training; habit reversal; and maintenance and relapse prevention 
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(McCracken & Turk, 2002). Cognitive-behavioral intervention has become a standard element 
for MCPM treatment (Kerns et al., 2011). 
Lastly, Acceptance and Commitment Therapy (ACT) (Hayes, Strosahl, & Wilson, 1999)  
is increasingly used in psychological intervention work with chronic pain. ACT differs from 
CBT in that rather than focusing on identifying, challenging, and changing their thoughts, 
patients are taught to observe and experience their thoughts and feelings as they are, without 
judgment or trying to change them. Some recent studies have indicated that psychological 
acceptance and flexibility are associated with improved treatment outcomes when compared with 
coping skills training (Clarke & Iphofen, 2007; McCracken, 2004). Acceptance of chronic pain, 
which is comprised of both a “willingness” to experience pain and to participate in valued 
activities in spite of ongoing pain, is associated with significant reductions in patient emotional 
suffering, improved functioning, and reduced healthcare use (Kerns et al., 2011). Recent studies 
indicate that pain acceptance (Vowles, McNeil, Gross, McDaniel, Mouse, Bates, Gallimore et al., 
2007) and psychological flexibility (McCracken, 2008) have begun to gain traction, with results 
showing more positive outcome and predictive power than previous treatments focusing on 
coping skills training or cognitive restructuring.  
Functional restoration  
Rehabilitation of physical and psychological functioning is considered an vital element of 
chronic pain management. A significant aspect of chronic pain is often a dramatic decrease in 
activity and physical deconditioning. As previously described, this is mediated by fear-avoidance 
behaviors and catastrophizing cognitions that focus on the belief that activity will cause more 
pain, the misunderstanding that the pain associated with activity is an indicator of further injury, 
and the belief that the severity of pain is a direct reflection of the underlying pathology 
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(Schoefferman, 2006). Functional restoration has several components including education 
regarding the nature of chronic pain and targeted towards mistaken beliefs about damage and 
pathology; exercise targeting increased strength, endurance, and flexibility; and progressive 
exposure to painful activities so that patients increase their self-efficacy and learn that it safe to 
engage in valued actions despite pain.  Importantly, functional restoration targets a person’s 
ability to engage in functional behaviors (sitting endurance, standing endurance, lift capacity, 
carrying capacity, overhead reach flexibility, range of motion flexibility, etc.) with goals that are 
quota based rather than pain based, and regular reinforcement of progress. Studies have indicated 
that this approach is effective for helping patients increase self-efficacy to manage their pain, 
begin to understand the nature of chronic pain (“hurt does not equal harm”), reduce perceptions 
of disability, and increase return to work (Shoefferman, 2002; Turk & Okifuji, 2002). 
Multidisciplinary chronic pain management 
These different modalities are now often integrated into MCPM programs that can consist 
of physiatry and other medical oversight, cognitive-behavioral therapies, medication 
management, physical and occupational therapy, functional restoration, and vocational 
rehabilitation (Adams, Poole, & Richardson, 2006; Fillingim, 1997; Kerns et al., 2011; Simon & 
Folen, 2001). Gate control theory (Melzack & Wall, 1965), Fordyce’s behavioral 
conceptualization of pain (1973), and the development of the biopsychosocial model (Engel, 
1977) sparked decades of intervention research that provided the foundation of comprehensive 
pain management, and MCPM programs (also referred to in the literature as “comprehensive” or 
“interdisciplinary” treatments) began to flourish during the 1980s (Gatchel & Okifuji, 2006; 
Kerns et al., 2011).  
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Programs are typically time-limited, ranging from 20 days to 8 months. Shorter programs 
tend to be more intensive, some meeting for 8 hours per day, 5 days per week. These are active 
programs, usually based on the biopsychosocial model of pain and a cognitive-behavioral 
approach to care. MCPM programs are typically comprised of professionals from multiple 
disciplines and may include physicians, neurologists, physiatrists, pharmacists, clinical 
psychologists, physical therapists, occupational therapists, nurses, and vocational counselors all 
of whom assess different aspects of the patient’s condition and work together to develop an 
integrated treatment plan addressing the varying dimensions (Simon & Folen, 2001).  
The underlying assumption of MCPM programs is that patients will adopt an internal 
locus of control and learn psychological and functional pain self-management skills, so that they 
are able to manage their pain and improve their functioning over a lifetime and decrease their 
reliance on external sources of pain control (Bruehl, 2006). A significant feature of these 
treatments is the emphasis on reducing sedentary behavior and increasing physical activity. 
However, comprehensive treatment not only focuses on functional improvements, but in helping 
patients reduce their suffering and develop the ability to self-manage their pain (Gatchel & 
Okifuji, 2006.)  
Psychoeducation plays a prominent role in these programs as studies have shown that 
patients need to increase their understanding of the different chronic pain models, so that they 
can understand that the absence of identifiable pathology does not indicate the pain is 
psychogenic or imaginary; they also need to understand the role of “pain management,” as their 
thoughts and beliefs about “adequate” pain treatment often present a barrier to accepting the 
rationale and engaging with the strategies that form the foundation of MCPM (Allcock et al., 
2007). Patients’ understanding and acceptance of the pain-management rationale and their own 
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self-efficacy are important aspects to treatment success. If patients believe they are not capable 
of controlling their symptoms, then they will likely put little effort into learning and using self-
management practices (Clarke & Iphofen, 2007; Turk & Okifuji, 2002).  
Evidence from meta analyses indicate these programs are effective at improving the 
physical and psychological functioning of its participants (Flor, Fydich, & Turk, 1992; Hoffman 
et al., 2007; Morley et al., 1999; Vlaeyen & Morley, 2005. Findings show) show CBT and 
MCPM interventions contribute to significant improvement in pain-intensity ratings, reduced 
pain behaviors, reduced disability, increased positive coping skills, and improved pain 
experience. Further, effect sizes calculated for behavioral or cognitive-behavioral treatment often 
exceed 0.50, indicating sizeable amounts of variance accounted for by the intervention (Gatchel 
& Okifuji, 2006; McCracken & Turk, 2002).   
One of the first major meta-analyses of MCPM programs (Flor et al., 1992) concluded 
that MCPM programs were more effective than no treatment, wait-list control, and single-
discipline therapies on outcomes such as healthcare utilization, medication use, activity levels, 
return to work, closure of disability claims, and improvements in emotional functioning. This 
meta-analysis reviewed studies that used an interdisciplinary approach to chronic pain treatment 
and included empirical data, published from 1960 to 1990. From an initial retrieval of over 300 
studies, a total of 65 met criteria for inclusion with 3,089 patients included, ranging from 5 to 
467 per study with an average of 61. They noted that significant majorities of the patients were 
characterized by high rates of unemployment, litigation and unemployment cases, multiple 
previous surgeries, and medication use. Behavioral and verbal-subjective measures of pain were 
the most widely used outcome measures and patients showed the greatest improvements on self-
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report measures of pain. The authors also found that patients treated in MCPM were nearly twice 
as likely to return to work (68% v. 36%) than those untreated or within single mode. 
In sum, Flor et al., (1992) found that treatment effect sizes were largest between 
treatment and no treatment, though these  were not far more significant than those between 
treatment and waitlist / medication.  The studies also indicated that both the within group and 
between group effect sizes were large and maintained at short- and long-term follow up. This 
study also found that at long-term follow-up, patients treated in MCPM centers were functioning 
better than 75% of samples treated with conventional, single modality treatments. The authors 
also found that several variables previously associated with poor outcome including chronicity, 
age, litigation and compensation in fact did not show significant correlations, though they 
cautioned that these findings were based on a small number of studies.  
A more recent meta-analysis employed “state of the art meta-analytic techniques to 
derive indices of the efficacy” (p. 6) of randomized controlled clinical trials of psychological 
interventions within outpatient MCPM programs treating non-cancerous chronic low back pain 
(Hoffman et al., 2007). Data were extracted from 31 separate research studies that met the 
following inclusion criteria: adults with chronic, nonmalignant pain of at least three months 
duration; presence of a comparison or control group; random assignment to groups; presence of 
pain-related outcome measures; and presence of psychological interventions. Outcomes 
measured included pain intensity, quality of life, and physical and emotional functioning 
compared to control groups (wait list and treatment as usual), as suggested by recommendations 
made by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials 
(IMMPACT; Dworkin et al., 2008). The following interventions were considered 
“psychological”: those characterized as psychological interventions by authors of published 
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studies and explicitly based upon behavioral, cognitive-behavioral, self-regulatory, or supportive 
approaches. For instance, a study was not considered to have an adequate psychological 
component if it provided physical therapy and medication management, whereas a treatment 
would that included physical therapy, relaxation training, and a pain management 
psychoeducation group. 
The results of the meta-analysis indicated that MCPM programs were superior to active 
control conditions following treatment at reducing pain interference (p < .05, d = .36) but not 
pain intensity (p > .10). MCPM programs were also found the be superior to active controls at 
improving percentages of patients who returned to work at both follow up (p < .05, d = .36) and 
long-term (d = .53).  MCPM programs were not found to be superior to active controls at follow 
up on measures of pain intensity or pain interference (p > .10). Overall, the authors noted that 
there was little support for comparative efficacy of psychological interventions compared with 
active controls with the exception of the superiority demonstrated by MCPM programs for 
behavioral outcomes including return to work when compared with single modality therapies. 
Furthermore, MCPM programs were found to be superior to other active treatment conditions at 
improving work related outcomes at both short and long term follow up (Hoffman et al., 2007).  
Notably, this results of this study also did not find substantive moderator effects, suggesting that 
patient and study characteristics did not impact treatment, though the authors noted insufficient 
data to examine factors such as race/ethnicity, education, pain duration, etc. 
Critics of MCPM programs have pointed to the possibility that complex and intensive 
(and expensive) programs are being provided to patients that perhaps could benefit from simpler 
treatments (Linssen & Spinhoven, 1992). Furthermore, the therapy has not been standardized and 
differs across different programs (Bruehl, 2006), though others argue that standardized treatment 
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fails to target specific interventions to specific patient symptoms (Gatchel et al., 2007). Bruehl 
(2006) points out that comprehensive treatment could entail any combination of medical, 
nursing, psychological, physical therapy, occupational therapy, vocational counseling, or 
recreation therapy, and that some sites are more comprehensive than others.  Furthermore, 
MCPM programs typically treat patients that have a wide range of diagnoses and mechanisms/ 
locations of pain with largely the same offering of interventions (Turk, 2005). Thus, many 
programs appear to operate under the premise that by providing multidisciplinary treatment 
(exercise, relaxation training, biofeedback, CBT, medication management, occupational therapy, 
nerve blocks, etc) to all patients, the appropriate interventions will address each patient’s 
individual needs.  However, as shown, studies indicate a wide variance in treatment response to 
MCPM, thought to be related directly to chronic pain patient heterogeneity (Gatchel et al., 2007; 
Turk & Burwinkle, 2005). 
Multidisciplinary/Interdisciplinary chronic pain management has been recognized as 
having the strongest evidence-basis for the treatment of chronic pain (IASP, 2012). However, the 
IASP reports that in 1999 it was estimated there were over 1000 interdisciplinary pain 
management programs in the United States, but that number has dropped dramatically to less 
than 150 as of 2011 (2012).  It seems that MCPM is not available to the vast majority of chronic 
pain patients in the US due to cost and lack of funding. The wide variance in treatment response, 
plays an important role in insurer’s unwillingness to pay for MCPM (Turk & Burwinkle, 2005). 
If reliable predictors of treatment response are not identified, the expense of these programs will 
likely make them unavailable to most patients.  
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Mediators and Moderators of Chronic Pain Management 
While there exist numerous behavioral, pharmacological, and surgical treatments for 
chronic pain, much of their ability to demonstrate long-lasting relief has not been substantial 
Pain patients are a heterogeneous population, and early outcome studies noted that even patients 
with the same medical diagnosis and physical pathology responded very differently to treatment 
(Turk & Okifuji, 1998). The variability in outcome increased awareness of the important role 
that psychosocial factors likely played in treatment. From 1960-1980, many researchers 
attempted to identify social factors related to pain, including ethnic and culturally-based 
responses to pain, however these studies resulted in contradictory conclusions (Thorn et al., 
2007). In 1982, Cairn, Mooney, and Crane (as cited in Turk & Okifuji, 1998), showed that 
variables other than medical diagnosis and physical pathology had a significant effect on 
treatment outcome, noting that initial medical diagnosis had limited prognostic value.  In 1990, 
Zatzick and Dimsdale (as cited in Wade and Price, 2002) concluded that there was little evidence 
that ethnicity or culture played a role in response to pain.  
These early studies seemed to indicate that emotional factors served as mediators and 
moderators in treatment, predicting potential treatment response, and often contributing to early 
termination from treatment (Coughlan, Ridout, Williams, & Richardson, 1995; McCracken & 
Gross, 1998).  Therefore, a great deal of research has been directed towards the identification of 
patient-related psychosocial factors that can be determined at assessment and which may aid in 
predicting successful treatment outcomes including demographic factors (race, ethnicity, sex, 
age), worker’s compensation status (Gatchel et al., 2002), physical disability, and medication use 
(Burns et al., 1998). Scores of psychological constructs have been evaluated including 
personality, attitudes, coping skills, stage of change, self-efficacy, fear of pain, emotional 
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distress, and program expectancies (Kreitler, Carasso, & Kreitler, 1989; Turk & Okifuji, 2002). 
A thorough review of these is beyond the scope of this paper, however a few of these will be 
reviewed here.  
Pain Intensity and Treatment Outcomes 
Patients prioritize pain reduction, improved sleep, and increased ability to engage in 
activities of daily living (Allcock et al., 2007). Patients have reported a strong motivation to 
determine the cause of their pain, indicating that this would provide “hope for a cure.” As noted, 
patients have strong beliefs in biomedical models of pain (there “must” be a physical cause 
otherwise the pain is imaginary), thus indicating that psychoeducation regarding the complexities 
of chronic pain might be an important element of treatment (Clarke & Iphofen, 2007).  Patients 
indicate a desire to make their pain more tolerable but equate this with pain reduction or pain 
relief. Some patients reported interest in reducing feelings of apathy and depression. Overall, 
having less pain or some pain-free times was ranked as the highest priority for pain patients and 
showed that physical improvements were a greater priority than emotional or social 
improvements.   
Since pain is subjective, self-report has been found to be the most valid measure 
(Melzack & Katz, 2001) and there are no objective measures. Patients are usually asked to 
quantify their pain using a numerical rating scale (e.g., scale of 1-10). Though this practice is 
nearly ubiquitous, this requires patients to retrospectively quantify and average their pain across 
time. Studies report that patients greatly overestimate their pain when recalling previous levels 
(Turk & Melzack, 2001). Also with few objective descriptions of each pain “level,” there is little 
standardization or way to discriminate between points on the scale.  Despite these limitations, 
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pain intensity is the most common measure of pain, and is usually measured by these numerical 
scales, verbal rating scales, or  visual analogue scales.  
There is little evidence that there are even divisions or meaningful differences between 
pain ratings. A patient may experience a two -point reduction in pain from 5-3 to be far more 
meaningful and impactful than a reduction from 8-6, therefore it is often difficult to ascertain the 
clinical significance (or, more importantly, the significance to the participant) of changes in pain 
intensity ratings although this is a primary focus of treatment for many programs (Dworkin et al., 
2002).   
Depression and Treatment Outcomes  
Dworkin, Richlin, Handlin, and Brand (1986), measured treatment outcome differences 
between depressed and non-depressed chronic pain patients. Patients were assessed on a Likert 
scale of 1-5 of no improvement to complete improvement, and outcomes were determined by 
patients’ pain intensity, level of activity, and medication use. The findings indicated that there 
were no demographic (sex, age, marital status, education level, or compensation status) 
differences between depressed and non-depressed patients.  Depressed patients were more likely 
to be involved in current litigation and more likely to be unemployed at their initial assessment. 
The pain-related variables included severity of medical history, number of different modes of 
prior treatment, and duration of pain, and both depressed and non-depressed patients were very 
similar. Despite the similarity, the authors found that the two groups differed dramatically in 
their pain descriptions, with depressed patients far more likely to report higher pain intensity and 
constancy, while non-depressed patients were likely to report mild or moderate pain that was 
intermittent. The authors noted however that it was impossible to ascribe causality or direction to 
these findings.  In evaluating response to treatment, it was found non-depressed patients 
EFFECTS OF OBESITY ON CHRONIC PAIN TREATMENT  
 
39
responded better if they were provided a greater number of treatment visit, did not receive time 
loss/ disability, had not tried multiple types of prior therapy, and were limited to low back pain.  
A different pattern of treatment response predictors was found for depressed patients, and a who 
were more likely to benefit when they had been employed prior to treatment and had experienced 
a shorter duration from injury to treatment. Although there were different treatment response 
predictors for each set of patients, the groups themselves did not differ in their response to 
treatment. Further research focused on specific moderating or predictive variables that influenced 
treatment outcomes such as personality, cognitive traits, and coping skills. Much of this centered 
on identifying patient subgroups based on psychosocial traits. 
Patient Subgroups 
An early study identified seven variables believed to predict treatment outcomes in 70% 
of subjects in an inpatient chronic pain program (Maruta, Swanson, & Swenson, 1979). The 
seven variables were 1) level of pain intensity, 2) duration of pain, 3) number of pain related 
surgical procedures, 4) dependence on analgesics, 5) loss of work time, 6) MMPI score on 
hypochondriasis scale and 7) MMPI score on hysteria scale. Response to therapy was evaluated 
in terms of a) modification of attitude, b) reduction in pain-related medication, and c) 
improvement of physical functioning.  Findings indicated that the ‘treatment failure’ group 
demonstrated significant differences from the ‘treatment success’ including longer duration of 
pain and loss of work time, greater number of previous pain related operations, pain levels of 
7/10 or above, significantly higher levels of narcotic dependency, and higher elevations on the 
hypochondriasis and hysteria scales on the MMPI.  
In an attempt to replicate these results with an outpatient population, Reich, Steward, 
Tupin, and Rosenblatt (1985) also added four psychosocial variables to improve the predictive 
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accuracy of the model.  These variables were 1) disruption of close personal relationship within 
previous 24 months, 2) altered body image due to loss of a visible body part or pain related 
change in physical activities, 3) history of severe, acute illness or injury before the age of 15, and 
4) a history of child abuse.  The results found no differences in outcome for age, sex, or level of 
education between treatment responders and non-responders, while the variables that had been 
included from the original study were found to be poor predictors of response to therapy. The 
additional variables were found to add some degree of specificity, but the study was limited by 
the fact that only 6 patients responded positively to treatment.    
Cipher and Clifford (2003) evaluated 66 patients with the McGill Pain Inventory,  BDI, 
and the MBHI and then categorized as them as either “Amplifiers, Repressors, or Social 
Copers.”  These patients underwent treatment at a MCPM program and were evaluated on 
reductions in pain, functional impairment, and depression levels.  While all three groups reported 
reductions in pain and functional impairment, only “Amplifiers” and “Social Copers” reported 
reduced levels of emotional distress and depression levels. Thus, the clients who were 
categorized as “Repressors” appeared not to have responded  to the CBT aspects of the program, 
and thus coping style appeared to differentiate who improved the most in treatment. The authors 
noted, however that Repressors began treatment with the lowest pre-existing levels of depression 
and anxiety, and thus might already have had adequately developed coping skills, and thus did 
not improve “as much.” 
However, additional studies have failed to find this patient grouping effect, noting instead 
that patient subgroups’ response to treatment appeared similar despite significant baseline 
differences (Gatchel et al, 2007; van der Hulst, Vollenbroek-Hutten, Groothuis-Oudshoorn, & 
Hermens, 2008). This finding suggested that all patients appear to benefit equally from treatment 
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in a variety of domains; the authors also suggested that psychological disorders, disability, 
coping resources, and narcotic medication use would not have to interfere significantly with 
effective pain treatment “as long as they (were) appropriately managed during the treatment 
process” (p. 143). While Gatchel et al., did not define how these issues were appropriately 
managed, they noted that there were no significant differences across subgroups in intensity or 
type of treatment.  Nevertheless, numerous additional studies have proceeded with the MPI-
identified patient subgroups, with an eye toward treatment matching. Though subgroups have 
been reliably reconstructed in further studies, there remains little evidence of treatment matching 
efficacy or clinical prediction models (Turk, 2005; van der Hulst et al.). Because of this, a 
growing focus on treatment moderators sought to identify subpopulations differentially affected 
by treatment and for whom effect sizes may mislead clinical decision making (Kramer, Frank, & 
Kupfer, 2006). 
Coping skills and patient subgroup research continued while other factors came under 
investigation. Many studies examined the role of a patient’s readiness to change (Gersh, Arnold, 
& Gibson, 2011; Strong, Westbury, Smith, McKenzie & Ryan, 2002). Built around Prochaska 
and DiClemente’s (1984) transtheoretical model of behavior change, researchers hoped to 
identify which patients were more likely to engage and respond to treatment, and perhaps 
identify which patients were at risk for premature termination.  Strong et al. developed the Pain 
Stages of Change Questionnaire (PSOCQ) in an effort to determine a patient’s readiness to adopt 
a self-management approach to chronic pain. In a study with 107 chronic pain patients assessed 
with the PSOCQ, the psychometric properties of the instrument did not prove to be reliable, and 
the transtheoretical model did not appear to adequately fit with chronic pain patients. Most 
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patients appeared to be in the contemplation stage prior to treatment, and outcome was better 
predicted by a patient’s movement through the stages during treatment than at baseline.  
Worker’s Compensation Status 
An important “subgroup” of chronic pain patients are those who have been injured on the 
job and are currently receiving disability payments (“time loss”) while they are unable to work 
and await possible compensation for their injury. Individuals in a MCPM program receiving 
workers’ compensation reported greater pretreatment interference with daily activities, more 
intense pain, and greater disability, and demonstrated poor outcomes than non-workers’ 
compensation patients, particularly if they had a history of pain related surgery (Burns, Sherman, 
Devine, Mahoney & Pawl, 1995). The authors suggested that the relationship between workers’ 
compensation status and outcome appeared mediated by the extent to which they believed they 
would be able to return to their former jobs. 
When treating worker’s compensation patients, it is important to consider that issues 
related to secondary gain are commonly seen as significant barriers to recovery (Gatchel, Adams, 
Polatin, & Kishino, 2002).  In their study with 158 patients participating in a MCPM program, 
Turk & Okifuji (1996) found that patients who were able to attribute their pain to a specific 
trauma reported significantly higher levels of pain intensity, emotional distress, and disability 
than those whose pain had insidious onset or unknown origin, regardless of physical findings. 
This suggests the context of pain has an impact on its intensity and degree of life disruption. 
Furthermore, in a study examining the role of beliefs and expectancies in chronic pain treatment, 
patient groups that attributed the blame for their pain their employer rather than to “no one” or to 
“other” (according to the authors, no one blamed themselves), reported greater mood distress, 
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behavioral disturbance, showed poorer response to treatment, and less optimism for future 
improvement (DeGood & Kiernan, 1996).  
However, disability behaviors that are thought to be reinforced by financial, vocational, 
and emotional reinforcers, do not apparently resolve themselves once these reinforcers are 
addressed (Gatchel et al., 2002).  Some evidence indicates that these factors do not necessarily 
create a major barrier to treatment as long as they are addressed, while perceptions of conscious 
malingering related to secondary gain may unfairly label a patient as unmotivated and prevent 
appropriate recognition of the substantial secondary losses associated with chronic pain.  The 
construct of secondary loss “acknowledges that a major loss can have long term, rippling effects 
that reach far beyond the initial even and that intensify the trauma” (Gatchel et al., 2002, p. 101).  
Secondary loss common to chronic pain includes the loss of physical functioning and 
independence, financial stability, family and social relationships, employment and family roles, 
self-esteem, self-concept, and general view of the world (Gatchel et al, 2002).  An additional 
challenge in treating worker’s compensation populations is the difficulty in adequately 
addressing patients’ loss of major social networks and their source of emotional and financial 
support. As studied by Jahoda (as cited by Gatchel et al, 2002), job loss not only leads to the loss 
of income, but also to the loss of professional esteem, socialization opportunities, a sense of 
purpose, and a structured organization to one’s activities and daily living.  
Methodological concerns in treatment outcome studies  
It is important to acknowledge the problems the field has had in evaluating the treatment 
efficacy of chronic pain management programs.  A primary problem has been the lack of 
consensus on the definition of outcome criteria (Dworkin, et al., 2008; Thorn et al., 2007; Turk et 
al., 1999).  “Successful” outcomes are differently defined by different stakeholders. Whereas a 
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patient would perhaps consider reduction or elimination of pain to constitute treatment success, a 
third-party payer (worker’s compensation insurer) might consider this negligible if it is not 
accompanied by a return to work or elimination of disability (Turk et al., 1993).  So too, even a 
reduction in pain can hold subjective significance, as a 3-point reduction in pain from 6-3/10 
might hold far greater importance  to a patient and their perceived disability than a 3 point drop 
from 9-6/10 (Dworkin, et al., 2008). 
Treatment outcome studies are limited as it is not clear what components of MCPM 
account for patient improvement, and thus identifying treatment outcome predictors and 
moderators can be difficult as the mechanism of change is rarely known. Due to a lack of fidelity 
to any specified protocol and efforts to “individualize” treatment, meta-analyses of MCPM are 
hampered by the number of outcome measures, heterogeneity of pain patient characteristics, and 
varying criteria for success between studies. Meta-analysis authors (Flor et al., 1992; Linssen & 
Spinhoven, 1992; Morley et al., 1999) report they are limited by treatment studies that have not 
included means and standard deviations for their reported outcome measures, do not include 
appropriate control groups, or use treatment drop-outs (sometimes as high as 87%) or those who 
refused treatment as controls. Few studies included information about the patient sample or study 
design and analysis. Lastly, this study was limited to multidisciplinary treatment of chronic back 
pain, and so its findings were not considered generalizable to treatments for other types of pain. 
(Flor et al., 1992). 
Chronic pain is a multidimensional, subjective, internal experience, but objective 
measures considered to be markers of treatment-related improvement are usually limited to 
simple measures of physical functioning. Furthermore, these measures of physical activity used 
as an outcome measure during a MCPM program are likely not to reflect the level of activity 
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characteristic of the patient, and may not transfer to the patient’s “real life” following treatment, 
thus treatment “gains” are not always maintained (Turk & Okifuji, 1998). In a recent 
commentary in the journal Pain, the IASP noted that patient outcomes are often not objectively 
measured and documented as a part of ongoing care, and recommended that the following 
particular outcomes be assessed using valid measures: patient reported pain intensity, physical 
and mental functioning, pain interference with mood, sleep, and physical function, and patient 
satisfaction with care (Ashburn & Witkin, 2012). While outcome studies have shown that use of 
valid self-report instruments can be effective (Gatchel & Okifuji, 2006) there is wide variability 
within treatment response. Much of the variability has stemmed the fact that patient’s diagnoses, 
conditions, and symptoms vary widely across studies (Thorn et al., 2007).  
Meta-analyses of outcome studies are hindered by the inconsistent intake measures and 
differing criteria for success across the various programs (McCracken & Turk, 2002; Vlaeyen & 
Morley, 2005). Outcome measures of pain treatment programs are typically a combination of 
performance-based measures (functional tolerances), global ratings by healthcare providers, 
external variables such as claim closure or return to work, reduction in pain behaviors, utilization 
of healthcare system, and self-report measures including emotional distress, pain related 
cognitions, activity levels, perceived disability, coping strategies, and medication use (Turk, 
Rudy, & Sorkin, 1993; Wittink et al., 2008). The lack of criteria for successful treatment is due 
to content differences in outcome, the variability between clinicians’ ratings of success versus 
patients’, vague definitions of outcome, outcomes that were reliant on extraneous, uncontrollable 
factors (e.g., return to work rates during a recession), and the stringency of definition of 
successful outcome. The lack of consensus and common measures makes comparisons of results 
between studies nearly impossible (Turk et al.) and studies are likely limited by data aggregated 
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from treatment responders with non-responders (McCracken & Turk, 2002; Vlaeyen & Morley, 
2005). Meta-analytic studies have typically focused on pain related to musculoskeletal back pain 
rather than the range of conditions that are present in chronic pain management treatment 
seekers, thus the generalizability of results is also called into question.  
Furthermore, many CBT programs and MCPM programs are “individualized” in order to 
target a patient’s particular needs. Thus, outcome studies do not often include enough 
information on the interventions make replication possible. A number of discrete interventions 
fall under the rubric of CBT and MCPM and there have been no specific techniques or 
therapeutic mechanisms identified which best predict patient response. There have been a wide 
variety outcome variables studied, and attempts at determining predictors of CBT and MCPM 
effectiveness have also been negatively impacted by inconsistent methodology, measures, and 
outcome variables across studies (McCracken & Turk, 2002; Thorn et al., 2007).  
Some additional limitations commonly found chronic pain research literature includes the 
selective bias in the referral process, lack of randomization and control groups, unacknowledged 
barriers to treatment, high drop-out rates, non-adherence to treatment recommendations, and 
strong risk of relapse (Turk & Rudy, 1990). Lastly, the questionable reliability of the self-report 
measures as the lack of normative data for these measures makes interpretation of outcomes 
(determination of clinically significant change) difficult to assess (Wittink et al., 2008).  
The IMMPACT conference recommended six outcome domains for pain researchers to 
focus upon during clinical trials: pain intensity, physical functioning, emotional functioning, 
participants’ own ratings of improvement and treatment satisfaction, symptoms and adverse 
events, and participant disposition (Dworkin et al., 2008). These recommendations attempt to 
capture domains important to the wide range of stakeholders involved with chronic pain 
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treatment in order to improve the clinical utility of findings and implement a common set of 
standards to improve comparison and meta-analysis studies (Hoffman et al., 2007; Thorn et al., 
2007).  Additional studies are now investigating treatment mechanisms within CBT and MCPM 
programs, focusing primarily on processes associated with CBT such as altering negative 
cognitions that contribute to maladaptive coping behaviors (Day, Thorn, & Burns, 2012).  
Obesity and Chronic pain 
Highly comorbid with chronic pain, obesity also dramatically affects health-related 
quality of life. Obesity and overweight are defined by the World Health Organization as 
“abnormal or excessive fat accumulation that presents a risk to health” (WHO, 2013, p.1).  Body 
Mass Index (BMI) is the standard used to calculate obesity by the WHO and is commonly used 
in research to calculate obesity, as it is considered to provide the most “useful” population-level 
measure of overweight and obesity due to its uniformity for both sexes and for adults of all ages 
(WHO, 2013). BMI is the ratio of weight to height and is calculated as weight in kilograms 
divided by the square of height in meters. It should be noted that BMI is an imperfect measure of 
obesity. While it is highly correlated with percentage of body fat, it does not distinguish between 
fat and lean tissue, so an individual with a significant percentage of muscle mass can be 
categorized as obese by this measure (Flegal, Carroll, Ogden & Curtain, 2010). Nevertheless, the 
following weight classifications are determined by BMI: underweight, BMI < 18.5; average 
weight, BMI = 18.5 – 24.9; overweight, BMI = 25.0 – 29.9; obese (mild), BMI = 30.0 – 34.9; 
obese (moderate) BMI = 35.0 – 39.9; and obese (severe/morbid) BMI ≥ 40 (Fabricatore & 
Wadden, 2006).  Based on BMI calculations, an individual standing 5’4” (64”) would be 
considered underweight if they weighed 107.8 pounds or less, would be considered a healthy 
weight from 107.8 – 145.4 pounds, would be considered overweight from 145.5 – 174.5 pounds, 
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would be considered obese from 174.6 – 203.6 pounds, moderately obese from 203.7 – 232.8 
pounds, and finally, severely obese if over 232.9 lbs. 
Obesity has been called a “national health crisis,” and is predicted to be the number one 
global health problem by the year 2025 (Vaidya, 2006). As of 2008, an estimated 68.0% of adult 
US residents were overweight or obese; the prevalence of obesity averaged 32.2% among adult 
men and 35.5% among adult women, and varied by age group and racial/ethnic group for both 
men and women (Flegal et al., 2010). In 2005, the International Obesity Task Force (as cited in 
Haslam & James, 2005) estimated that approximately 1.1 billion adults met criteria for being 
overweight, including 312 million meeting criteria for obesity.  In 2009 – 2010, the age-adjusted 
mean BMI among US adults was 28.7 for men, and 28.7 for women, while the median BMI was 
27.8 for men and 27.3 for women (Flegal, Carroll, Kit, & Ogden, 2012). Rates of obesity 
increase across the lifespan particularly during middle to older age, which has been associated 
with several psychosocial and behavioral variables including cohabitation (hypothesized to be 
related to increased meal portion sizes for women), repeated pregnancies, and the progressive 
decrease in physical activity (Haslam & James, 2005).  Prevalence varies according to 
socioeconomic status (SES), and in developed countries such as the US, there is a far higher 
prevalence of obesity in lower SES groups (Vaidya, 2006). Changes in BMI across the US have 
mirrored changes in rates of obesity, and though these increased dramatically from 1980 – 1999, 
recent data suggest a leveling off of this trend (Flegal et al., 2012). The negative impacts of 
obesity are wide ranging and include financial and economic costs, public health consequences, 
and individual physical and psychosocial consequences. Furthermore, it appears that obesity 
interacts with other conditions such that it aggravates and exacerbates their severity, or possibly 
acts as a moderating factor in treatment.   
EFFECTS OF OBESITY ON CHRONIC PAIN TREATMENT  
 
49
 From a financial perspective, the steep health-care costs related to the multitude of heath 
conditions due to obesity are predicted to significantly increase an individual’s Medicare costs 
compared to normal weight individuals (Cai, Lubitz, Flegal, & Pamuk, 2010). Previous research 
by van Heuvel, Boshuizen, & Hildebrandt (as cited by Kyrolainen, Santtila, Nindl & Vasankari, 
2010)  has shown that physically active (and comparatively less likely to be obese) employees 
had significantly reduced absenteeism. Additional studies have shown that high BMI, poor 
muscle strength, and impaired endurance were risk factors for reduced productivity (Kyrolainen, 
Hjakkinen, Kautianinen et al., 2008).  Additionally, high BMI and smoking have been shown to 
be the strongest predictors of sickness-related absenteeism, particularly for medically-confirmed 
absence, in fact doubling the risk in male employees, and nearly doubling the risk for 
absenteeism in female employees (Laaksonen, Piha, Martikainen, Rahkonen, & Lahelma, 2009).  
From a public health perspective, the New England Journal of Medicine noted that 
morbidity related to obesity increases so significantly, that overall life-span of the US population 
could potentially decline over the 21st century (Olshansky, Passaro, Hershow, Layden et al., 
2005). Obesity is a significant public health concern associated with numerous health conditions 
including chronic pain, type 2 diabetes, heart disease, hypertension, metabolic syndrome, breast 
cancer, polycystic ovary syndrome, dyslipidemia, stroke, gout, gallstone disorder, osteoarthritis, 
and significant psychological disorders (Centers for Disease Control, 2011; Haslam & James, 
2005). The respiratory effects of obesity are significant and have a strong effect on health related 
quality of life, and numerous studies indicate that obesity is highly correlated with reduced 
physical fitness and activity and increased sedentary lifestyles (Kyrolainen et al., 2010; Marcus, 
2003). The greatest impairments associated with obesity are found in social functioning, general 
health status, physical functioning, vitality, and the role limitations caused by physical disability 
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and limited mobility (Barofsky, Fontaine, & Cheskin, 1997). In addition to physical disability 
that impairs in activities of daily living, obesity has been linked to depression, anxiety, and 
psychological disability.  Successful treatment of obesity has been shown to improve all these 
physical and psychological aspects of life (Marcus, 2003; Sullivan, Karlsson, Sjostrom, et al., 
1993). 
It can be difficult to discriminate between the social and pathophysiological 
consequences of obesity and weight gain when evaluating the relationship between 
psychological health and obesity. However, obesity has been well-established as having a 
negative impact on physical well-being, though results have inconsistently demonstrated its 
relationship to psychological disturbance (Doll, Petersen, & Stewart-Brown, 2000).  Findings 
from the 2005 Behavioral Risk Factor Surveillance System, a large-scale study of US adults 
using ongoing, random-digit telephone survey of the U.S. adults, indicated that persons who 
were “dissatisfied/very dissatisfied” with their lives were 1.5 times more likely than those very 
satisfied to be obese, and 2.2 times more likely to be physically inactive (Strine, Chapman, 
Balluz, Moriatry, & Mokdad, 2008).  Large epidemiological studies have found that two obese 
subgroups, women and the severely obese, are at increased risk of depression (Fabricatore & 
Wadden, 2006). While the prevalence of psychiatric comorbidity in community-based obese 
populations is similar to non-obese groups, there is a significant increase in psychiatric problems 
in obese patients seeking treatment.  
  There are no studies that show a specific pattern of personality traits associated with 
obesity (Davin & Taylor, 2009; Vaidya, 2006).  However, it is noted that slimness is idealized in 
most developed societies so overweight individuals, particularly women, are often subject to 
discrimination and stigma, and may suffer from feelings of poor self-esteem, anxiety, and 
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depression in relation to their excess weight (Haslam & James, 2005), though these effects are 
found to be moderated by gender (Vaidya, 2006). Obesity increases the risk of a diagnosis of 
major depression in women by 37% while obese men have a 37% reduced risk of depression in 
comparison to healthy weight men.  As noted, aspects of psychological distress are mediated by 
treatment seeking for obesity (bariatric surgery), as bariatric surgery candidates often have far 
greater rates of depression and anxiety than obese individuals not seeking treatment (Fabricatore 
& Wadden, 2006). The relationship between BMI and depression is likely mediated by the 
impact of obesity on health-related quality of life (Fabricatore & Wadden, 2006.) 
While numerous epidemiological and clinical studies have noted the association between 
being overweight/obese and psychopathology in obesity treatment seeking populations, obesity 
has also been found to impact treatment outcomes in psychiatry research directed towards mood 
disorders. Several studies have noted that obesity is related to poorer outcome in the treatment of 
bipolar I disorder (Fagiolini, Kupfer, Houck, Novick, & Frank, 2003; Faitha, Calamaroa, Dolana, 
& Pietrobelli, 2004; Hainsworth, Davies, Khan, & Weisman, 2009) with findings indicating that 
obesity is associated with poorer response to antidepressants and mood-stabilizers.  Fagiolini et 
al. (2003) evaluated the demographic and clinical characteristics and treatment outcomes of 175 
patient with bipolar I disorder who were being treated for an acute affective episode and then 
monitored through a period of maintenance treatment. Results indicated that obese patients (n = 
62, 35.4%) experienced a greater number of lifetime affective episodes, presented with more 
severe and less-responsive to treatment index affective episodes, and were at greater risk to 
experience depressive recurrences.  Specific results showed that in comparison to non-obese 
participants, obese participants were less educated, reported greater numbers of previous manic 
episodes, more previous depressive episodes, and higher baseline Hamilton depression scale 
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scores. Further, obese patients required increased treatment time in order to attain stable 
remission and showed a significantly shorter maintenance phase between acute affective 
episodes. Additionally, obese patients showed significantly greater numbers of depressive 
recurrences.  
It appears that a similar response was found with unipolar depression studies. Results 
from the Munich Antidepressant Response Signature Study indicated that patients with high BMI 
(≥25) showed slower clinical response, less improvement in neuroendocrinological (plasma 
cortisol and adrenocorticotropin (ACTH)) levels, and less improvement in cognitive speed and 
attention than patients with normal BMI (<25) during antidepressant treatment (Kloiber, Ising, 
Reppermund, Horstmann, et al., 2007). 
The rates of comorbidity between obesity and chronic pain are primarily gathered from 
community based studies and obesity research, as BMI appears rarely reported in chronic pain 
research.  Findings from the community based University of Washington Twin-Registry showed 
that overweight and obese twins were significantly more likely to report low back pain, 
headache, fibromyalgia, abdominal pain, and chronic widespread pain more than normal-weight 
twins after adjusting for age, gender, and depression (Wright et al., 2010).  Previous findings 
have also demonstrated that black patients with chronic pain are at higher risk for obesity and 
morbidity than white patients with chronic pain (Caldwell, Hart-Johnson, & Green, 2009).  
In another study looking at the association between obesity and health-related quality of 
life, found that out of nearly 8,600 respondents, approximately 33% were overweight (n = 2682, 
31%) and or obese (n = 921, 11%); and more than 55% of overweight and obese respondents 
suffered from at least one co-morbid chronic illness, most frequently back pain or joint pain 
(Doll et al., 2000).  
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The impact of chronic pain upon obesity patients is frequently studied though the 
corollary may not be true. It appears that obese persons with chronic pain are significantly more 
impaired across multiple domains than obese persons without pain (Barofsky, Fontaine & 
Cheskin, 1997; Caldwell et al., 2009; Doll et al., 2000; Hainsworth, et al., Marcus, 2004). In a 
sample of obese patients seeking university-based weight management, over one-half presented 
with chronic pain, including low back pain, arthritis, chronic headache, and chest pain (Barofsky 
et al., 1997). Even when controlling for BMI, these patients were significantly impaired in all 
areas of health-related quality of life, sociodemographic factors, and depression, indicating that 
pain played an important role beyond the limitations imposed by obesity.  
In a community sample, participants reporting co-morbid obesity and chronic illness 
(particularly back and joint pain), reported particularly poor physical and emotional well being 
when compared with individuals that were normal weight/health, or who suffered from chronic 
illness or obesity independent of one another (Doll et al., 2000).  While studies show that obesity 
itself is not a reliable, independent risk factor for emotional disturbance, (Wadden & Stunkard, 
1987), the Doll et al. study provided additional evidence that obesity likely compounds the 
physical and emotional disability often associated with chronic pain. Obesity impairs walking 
ability and exacerbates pain when walking; further, difficulty with walking is an early predictor 
of pain related disability (Vincent et al., 2011). Obesity alone contributes to lower back pain due 
to lumbar weakness, poor quality skeletal muscle, poor balance, and strength deficits in back 
muscle;  it is a prime contributor to joint pain and arthritis in the knees and hips  (Haslam & 
James, 2005).  
Obesity is also common in fibromyalgia patients and has been associated with greater 
pain sensitivity, reduced physical strength, reduced flexibility, and poorer sleep quality (Okifuji, 
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Donaldson, Barck, & Fine, 2010).  Furthermore, a positive linear relationship has been found 
between BMI and levels of inflammatory markers such as interleukin-6 and C-reactive protein 
and levels of stress indicators such as cortisol and epinephrine in fibromyalgia patients, factors 
likely related to the poorer sleep quality and greater pain sensitivity (Okifuji, Bradshaw, & 
Olson, 2009). Okifuji, Bradshaw et al. also found that obese patients demonstrated reduced 
degrees of fitness as evidenced by shorter treadmill walking distance accompanied by higher 
maximum heart rate. The implication of this is that obesity may present a barrier to activating 
and physically-based therapies, which are common components of pain management.  
Further, people with higher BMI appear to be more sensitive to chronic pain (Wood, 
Goodnight, Haig, and Nasari, 2011).  In a study examining the relationship between obesity, 
hypertension, and chronic pain, Wood et al. found no significant correlation between pain rating 
and BMI as a continuous variable (though they reported that it “approached significance”). 
However, ANOVA results indicated a statistically significant difference in BMI for patients with 
low pain ratings (0-3/10) versus those with high pain ratings (7-10/10), with those reporting high 
pain ratings having significantly higher BMIs though the effect size was small [F(2,172) = 3.63, 
p = .03, η2 = 0.04). Obese patients in this study also reported a higher incidence of narcotic use 
for pain despite similar pain intensity ratings, which the authors interpreted as a possible lower 
tolerance for pain.  
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Obesity, Depression and Health-Related Quality of Life 
Obesity is also believed to increase pain severity and disability also due to increased 
psychological distress. Further, obesity is strongly related to disability for engaging in activities 
for daily living and occupational functioning, which in turn diminishes quality of life.  Marcus 
(2003) found that in a sample of chronic pain patients seeking treatment, obese patients were 
significantly more likely to endorse severe levels of depression, though there were no differences 
in anxiety between obese and non-obese patients. Further, pain severity was not related to 
weight, but increased weight was significantly associated with increased disability and impaired 
physical functioning. Based on these findings, the author suggested that obesity serves as a 
marker of disability and depression in patients seeking treatment for chronic pain, thus patients’ 
weights should be included in pain assessment as patients with obesity might benefit from a 
greater intensity of treatment, targeting both depressive symptoms and disability. 
While the relationship between pain and obesity is typically attributed to the mechanical 
problems caused by obesity, studies suggest that obese persons with pain have significantly 
higher levels of pain catastrophization (Vincent et al., 2011). In a study evaluating the impact of 
obesity on physical therapy, fear of movement and pain catastrophizing was found to be far more 
severe in obese adults than non-obese adults with chronic low back pain, despite similar pain 
ratings and depression severity.  
Barofsky et al. (1997) investigated the impact of pain in a population of obese patients on 
health related quality of life.  In a sample of 312 patients seeking treatment for obesity at the 
Johns Hopkins Weight Management Clinic, 47.7% reported moderate to severe chronic pain at 
the start of treatment. There were no differences between obese patients with pain and obese 
patients without pain on demographic measures or levels of depression. However, they found 
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that obese persons reporting pain were significantly negatively impacted on all health related 
quality of life domains on the SF-36, including physical functioning, physical role, general 
health, vitality, social functioning, emotional roles, and mental health. Based on the lack of 
differences on demographic measures, the authors reported that chronic pain appeared to be 
associated with significant impairment in health-related quality of life independent of obesity, 
depression, or socio-demographic factors.     
However, in a community-based study, BMI was significantly associated with health-
status, but the effect varied according to whether the measure reflected well-being in a physical 
or emotional domain (Doll, Petersen, & Stewart-Brown, 2000). 9,000 adults were surveyed using 
the Multidimensional Short Form (SF-36), a self-report, 36-item, Likert scale or forced choice 
measure that evaluates health related quality of life in the following domains: Physical 
Functioning, Role Limitations due to Physical Functioning, Bodily Pain, General Health, 
Vitality, Social Functioning, Role Limitations due to Emotional Functioning, and Mental Health. 
Lower scores are indicative of reduced health-related quality of life.  This measure has been 
shown to have excellent construct validity, high internal consistency, and high test-retest 
reliability (Yancy, Olsen, Westman, Bosworth, & Edelman, 2002).  In this study,  31% (n = 
2,682) of respondents were overweight, and an additional 11% were either moderately obese 
(10%, n = 852) or severely obese (1%, n = 69).  Increasing BMI was found to be linearly 
associated with reporting a long-standing illness and frequency of health service utilization. The 
association of increased BMI with pain also resulted in reduced scores in physical well-being 
independent of the number of chronic illnesses reported. Overweight and obesity were strongly 
associated with diminishing levels of physical and emotional well-being, though the effect was 
far more pronounced in measures of physical well-being. The authors stated that these result 
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supported previous findings that the consequences of obesity were found to be primarily physical 
rather than emotional.     
Numerous studies have demonstrated the positive relationship between weight and 
depression in women, thought to be mediated by impairments in health-related quality of life 
(Fabricatore & Wadden, 2006). In their research looking at the relationship between obesity and 
health-related quality of life in men, Yancy et al. (2002) found an strong relationship between 
BMI and the physical domains of health-related quality of life. Of the 1,168 male participants in 
the study, 43% (n= 507) were overweight, 25% (n = 292) were obese, 8% (n = 98) were 
moderately obese, and 3% (n = 30) were morbidly obese.  Overall, 79.3% were overweight or 
obese.  After controlling for age, race, comorbid illness severity, depression, and physical 
activity, individuals with morbid obesity (BMI ≥ 40) scored significantly worse than average- 
weight participants on 5 of 10 subscales: Physical Functioning, Role-Physical, Bodily Pain, 
Vitality, and Physical component Summary.  Even overweight individuals (BMI from 25 to 29.9) 
reported significantly greater problems with bodily pain compared with normal weight 
individuals.  
Chronic Pain and Treatment for Obesity 
Chronic pain is considered one of the primary barriers to the diet and exercise 
components of obesity treatment (Mauro, Taylor, Wharton, & Sharma, 2008). In a qualitative 
study investigating the experience of patients with comorbid obesity and chronic pain, Janke and 
Kozak (2012) found that patients perceived depression as amplifying their comorbid somatic 
symptoms and interfering with treatment in numerous ways.  Patients reported that hedonic 
hunger (eating for pleasure) and emotional/binge eating were triggered by physical pain and 
resulted in additional guilt and shame. Patients also reported making unhealthier food choices in 
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response to pain. Importantly, patients reported experiencing far lower self-efficacy for physical 
activity due to pain and far greater levels of disability.  
Obesity and Treatment for Chronic Pain  
One important study examined the effects of obesity on pain coping skills training 
(PCST) and lifestyle behavioral weight management (BWM) (Somers, et al., 2012). In this study, 
overweight or obese participants with osteoarthritis were randomly assigned to a six-month 
treatment program examining the differences between PCST + BWM, PCST-only, BWM only, 
or treatment as usual. Results indicated that patients who were provided PCST + BWM 
demonstrated significantly better outcomes in numerous domains including pain, disability, and 
self-efficacy. The authors noted that the emphasis in reducing catastrophizing and anxiety, and 
improving self-efficacy, as found in the combined condition, may have contributed to the better 
outcomes.  The authors of this study recommended that overweight or obese patients with osteo-
arthritis be provided concurrent training in pain coping skills and weight management in order to 
provide greater long-term benefits.  
Obesity and Cognitive-behavioral Treatment for Chronic Pain 
The literature indicates that obese patients with chronic pain often experience greater 
levels of depression and impaired self-efficacy related to their weight, reduced health related 
quality of life, and greater perceived disability. With obesity’s impact on so many dimensions 
related to chronic pain, it seems unsurprising that a recent study evaluating cognitive-behavioral 
treatment of chronic pain patients found that obesity was a significant moderator of patients’ 
ability to benefit from treatment (Sellinger et al., 2010). The authors compared the treatment 
outcomes of obese and non-obese chronic pain patients and found that non-obese participants 
showed greater improvement following treatment than obese participants on measures of 
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disability (p<.05), physical aspects of quality of life (p<.01), and emotional functioning (p<.05). 
It is unknown to what degree this treatment included a multidisciplinary component that would 
also emphasize physical conditioning, occupational therapy, and operant behavior shaping, but 
the entire treatment was delivered by psychologists rather than an integrated treatment team. It 
appeared that there were few differences found in emotional functioning post-treatment aside 
from depression scores, but this may be related to small sample size (N = 74) and a lack of 
statistical power.  
Based on this review of the literature, one might hypothesize several possible reasons 
why obesity may function as an added emotional and physical stressor that negatively impacts 
MCPM. In particular, important psychosocial chronic-pain management outcomes related to pain 
intensity, emotional functioning, fear of movement, self-efficacy, and perceived disability have 
been shown to be also responsive to obesity, such that participants with these co-morbid 
conditions will present as more severe treatment cases and show impaired response to treatment. 
Additionally, an increase in exercise provides a multitude of benefits, both psychological and 
physical, and previously sedentary adults derive benefit from even modest exertion (Haslam & 
James, 2005).  It is possible that the increase in physical activity that is a component of MCPM is 
highly associated with patient improvements in emotional and physical functioning.  If a patient 
is unable to fully engage with this increased physical activity due to obesity, they may derive less 
benefit from the treatment overall.  
As of 2013, there appear to be no published outcome studies evaluating the role obesity 
plays in treatment outcomes for MCPM programs. These programs have been shown to provide 
effective treatment for chronic pain, but response to treatment is impacted by a wide variety of 
variables, which have inconsistent interactions with treatment effects. While MCPM has been 
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shown to be as effective as biomedical interventions (Turk & Okifuji, 2006), it is important to 
know what factors impact treatment outcomes. With estimates of obesity ranging from 35-50%, 
particularly for chronic pain patients,  and based upon the numerous ways in which chronic pain 
and obesity interact, it is worth considering that obesity may contribute to the variance found in 
treatment outcomes, thus playing a moderating role in showing what treatments work for whom. 
MCPM is considered an expensive treatment and there have been no published studies looking at 
the impact of obesity on a patient’s ability to benefit from MCPM. If there is an interaction 
between treatment and obesity, MCPM programs can begin to develop targeted treatments to this 
specific subset of patients and outcome studies can better control for this possibly influential 
patient characteristic.  
Thus, the literature shows that obesity is linked with greater impairments in emotional 
functioning, a differential treatment response to anti-depressant medications, lower levels of 
physical activity, greater deconditioning, reduced response to physical therapy, an increased fear 
of movement, and greater levels of perceived disability. It may be expected that individuals with 
comorbid chronic pain and obesity would also be characterized by these impairments. 
Furthermore, chronic pain has been shown to act as a barrier to treatment for obesity, often 
functioning as a stressor that contributes to reduced physical activity and increased 
hedonic/emotional eating. While obesity is a well-known risk factor for chronic pain, and 
chronic pain has been shown to moderate obesity treatment outcomes, there has been little 
published research examining the role of obesity in chronic pain treatment.  Although it has been 
demonstrated that obesity and chronic pain are often comorbid and have an interdependent 
relationship with one another, there is little research that has shown what role obesity plays in 
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comprehensive treatment for chronic pain. This study attempted to address this gap in the 
literature. 
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Hypotheses 
The purpose of this study was to compare the treatment outcomes of obese versus non-
obese participants in a 20-day chronic pain management program. By retrospectively examining 
two years of treatment records and comparing treatment outcomes of different participant 
groups, this study sought to provide insight into the demographics of overweight and obese 
patients within a chronic pain population, and examine the potential for differential emotional 
functioning and response to treatment. The following hypotheses were tested: 
 
1. It was expected that weight status as measured by body mass index (BMI) would predict 
differences in response to treatment, such that participants with BMIs equal to or greater 
than 30 (obese) would have higher rates of treatment drop-out than participants with 
BMIs lower than 30.  
2. It was expected that participants in a MCPM program would show statistically significant 
change (improvement) from pre-treatment (Time 1) to post-treatment (Time 2) on 
measures of pain intensity (Pain), depression (BDI-II), anxiety (PASS), self-efficacy 
(PSEQ) and perceived disability (PDQ). 
3. It was expected that improvements on measures of pain, depression, anxiety, self-
efficacy, and perceived disability would vary according to whether a participant was 
classified as Obese or Non-Obese.  
4. It was expected that obese participants would report higher levels average pain intensity,  
in comparison to non-obese participants, as measured by numerical pain-rating scores 
(NRS).  
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5. It was expected that obese participants would report more severe depressive symptoms in 
comparison to non-obese participants, as measured by scores on the Beck Depression 
Inventory (BDI-II). 
6. It was expected that obese participants would report greater pain-related fear and anxiety 
in comparison to non-obese participants, as measured by scores on the Pain Anxiety 
Symptom Scale (PASS).  
7. It was expected that obese participants would report less ability to self-manage their pain 
in comparison to non-obese participants as measured by scores on the Pain Self-Efficacy 
Scale (PSEQ).  
8. It was expected that obese participants would report greater levels of perceived disability 
than non-obese participants, as measured by scores on the Pain Disability Questionnaire 
(PDQ).  
9. It was expected that weight status (obese versus non-obese) would predict reductions in 
pain intensity, such that the mean change in pain intensity, from pre to post-treatment, 
would be less for obese participants than non-obese participants.  
10. It was expected that weight status would predict reductions in depressive symptoms, such 
that the mean change on the BDI-II, from pre to post-treatment, would be less for obese 
participants than non-obese participants.  
11. It was expected that weight status would predict reductions in pain related fear and 
anxiety, such that the mean change on the PASS, from pre to post-treatment, would be 
less for obese participants than non-obese participants. 
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12. It was expected that weight status would predict improvements in ability to self manage 
pain, such that the mean change on the PSEQ, from pre to post-treatment, would be less 
for obese participants than non-obese participants.  
13. It was expected that weight status would predict improvements in perceived disability, 
such that the mean change on the PDQ, from pre to post-treatment, would be less for 
obese participants than non-obese participants.  
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Method 
 
Design 
In order to evaluate whether obesity moderated MCPM treatment outcomes, this study 
conducted retrospective analyses of patient medical records and outcome data from a community 
based comprehensive pain-management clinic. The total data set was comprised of 221 
participants who consecutively completed a 20-day pain-management program over a period of 2 
years. Data consisted of demographic and health-related data, in addition to results from pre- and 
post-treatment assessments of pain intensity, depression, pain-related anxiety, perceived 
disability, and self-efficacy in managing pain. These assessment data were captured by 5 self-
report measures provided at intake and discharge. At the time of treatment, there was no 
consideration of the participants’ BMI, nor was this information incorporated into treatment in 
any way. The retrospective data were divided into obese and non-obese groups using BMI for 
comparison, using specific criteria described below. The data were analyzed for both within-
group change related to treatment and between-groups change in relation to weight status.  
Participants  
Participants were patients treated consecutively through the Progressive Rehabilitation 
Associates multidisciplinary chronic pain management program during the years 2009 to 2011. 
Patients were referred to treatment by their physicians or by their worker’s compensation 
systems. The primary goal of the program is to restore functional tolerances so that a patient may 
return to the workforce at an adequately assessed level; another goal is to evaluate the patient’s 
history and condition in order to rate them as stable (“Maximally Medically Improved”) or in 
need of further treatment. Upon treatment completion and stable rating, participants who were 
referred by their worker’s compensation system were usually provided a return-to-work rating, 
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and their worker’s compensation cases settled and closed. Upon closure of a worker’s 
compensation case, there is often a financial settlement and a patient’s “time-loss” (paid benefits) 
are concluded.  The exclusion criteria for the program were limited to inability to pay, active 
psychosis, recent surgery requiring further recovery prior to rehabilitation, and an absolute 
refusal to enter the program. There was no information available regarding patients who were 
evaluated by the program but were not admitted or chose not to enroll.  
The sample consisted of 221 individuals, the majority of whom were male (n = 144, 
65.15%) and Caucasian (n = 187, 84.61%). One patient was African American, while 33 
(15.2%) patients were Latino; of these Latino participants, many were Spanish-speaking only 
(exact number and percentage unknown) and were accompanied at all times by an interpreter 
provided by the clinic.  The mean age of the sample was 44.89 years (SD = 9.98), with a range of 
20 – 81 years old. The majority of patients (n = 210, 95.02%) were referred by worker’s 
compensation systems primarily within Oregon and Washington State. All patients had at least a 
3-month history of pain unresponsive to medical treatment prior to entering the program, though 
the majority had experienced considerably longer injury-treatment intervals, with an average of 
44 months (SD = 50.09) between injury and treatment intake. 43% (n = 95) of the sample met 
criteria for obesity (BMI  ≥ 30), with a BMI range of 19 – 52, and a mean BMI of 30.07 (SD = 
6.39).   
The participants had varying types of mechanism of injury, including headache, 
musculoskeletal injury, osteoarthritis, neuropathic deterioration, and non-specific (i.e., 
fibromyalgia).  The majority (47.5%) were related to lumbar pain and dysfunction (n = 105). A 
significant portion of the participants had previously sustained severe injuries related to 
industrial accidents (e.g., run over by a tractor-trailer), and there were varying degrees of 
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disability, pain, and psychopathology as measured at intake.  See Table 1 for more demographic 
information of the total sample.  
Table 1 
Total Sample Demographic Characteristics 
 
Demographic 
 
N 
 
Mean (SD) / % 
 
Age 221 44.89 (9.98) 
Gender 
     Male 
     Female 
 
144 
77 
 
65.15% 
34.84% 
 
Race 
     Caucasian 
     Other 
 
187 
34 
 
84.61% 
15.38% 
 
Education 
   <High school 
     High school Graduate/GED 
     Some College / Certificate 
     College graduate 
 
29 
79 
88 
25 
 
13.2% 
35.7% 
39.8% 
11.3% 
 
Referral Source 
     Worker’s Compensation 
     Private Clinician 
 
210 
11 
 
95.02% 
4.08% 
 
Type Employment at Injury 
     Heavy labor 
     Low skilled labor 
     Skilled professional 
 
81 
100 
40 
 
36.65% 
45.25% 
18.10% 
 
Employment Status at Intake 
     Time loss / Worker’s compensation 
     Unemployed / no income 
     Employed 
     Permanent Disability / Retired 
 
160 
17 
17 
27 
 
72.40% 
7.69% 
7.69% 
12.22% 
 
Pain duration (months) 221 44.09 (50.09) 
Morphine equivalency (pretreatment) 153 67.53 (71.67) 
Average pain intensity (pretreatment) 221 6.35 (1.47) 
Location of Pain 
    Upper Body  
    Lower Extremity 
    Lumbar 
    Multiple 
 
59 
19 
106 
37 
 
26.7% 
8.6% 
48.0% 
16.7% 
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Obesity was assessed according to the World Health Organization’s standard BMI 
Of the 221 participants, 96 (45%) met criteria for obesity with a BMI 
not meet criteria for obesity. The mean BMI of the sample was 30.01. Further breakdown 
revealed that 22.17% (n = 49) of the total sample had a BMI within a normal
≤ 24.9).  The greatest proportion of patients (34%, 
on a BMI between 25 and 29.9. “Mildly” 
21.27% (n = 47) of the total sample
obese participants (BMI ≥ 35); see 
Figure 1. Proportions of weight status based on BMI
 
  
 
≥ 30, while 125 (55%) did 
-weight range (
n = 76) were classified as overweight based 
obese participants (BMI = 30.0 – 34.9) comprised 
, while the remaining 22.17% (n = 49)  consisted of severely 
Figure 1.   
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Measures 
Weight Status. For the purposes of this study, BMI was used to calculate obesity as this is 
the measurement standard employed by the World Health organization, which defines 
underweight, BMI < 18.5; normal weight, BMI = 18.5 – 24.9; overweight, BMI = 25.0 – 29.9; 
obese (mild), BMI = 30.0 – 34.9; obese (moderate/severe) BMI ≥ 35.0. BMI is the ratio of 
weight to height and is calculated as weight in kilograms divided by the square of height in 
meters.  BMIs above the cutoff of 30 are associated with an increased risk for weight-related 
health concerns (Fabricatore & Wadden, 2006).  For this study, BMIs were calculated from the 
height and weight gathered at the patient’s initial medical evaluation by the clinic, retrieved from 
the patient’s electronic medical record, and converted to BMI and appropriate weight category 
for analysis. 
Average Pain Intensity. Patients were asked to rate their least, worst, and average pain 
intensity over the previous week using a self-report Numerical Pain Rating (NRS) that ranged 
from 0 (“no pain”) to 10 “worst pain imaginable.” As pain is a subjective experience, self-report 
has been found to be the most reliable and valid measure (Melzack & Katz, 2001) and NRS is a 
standard instrument used in research and clinical contexts. For the purpose of this study, average 
pain ratings provided at intake and discharge interviews were used in order to best understand 
the participant’s overall pain experience. A reduction in average pain intensity by 20% is 
generally considered clinically significant (Dworkin et al., 2008).  
Depression. The Beck Depression Inventory, 2nd edition (BDI- II; Beck, 1996) was used 
to assess patients for cognitive, somatic, and emotional components of depression. The items on 
this measure also relate to somatic complaints such as sleep disturbance, lack of energy, and 
weight change that can also be directly linked to chronic pain, and thus may inflate scores 
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somewhat.  It has been found to discriminate well between patients with and without depression 
(Harris & D’Eon, 2008). The BDI-II is a 21-item self-report measure designed to assess 
symptoms of depression in adolescents and adults. It provides a single overall score ranging from 
0 to 63. Test takers rate various depressive symptoms from 0 (not present) to 3 (severe), based on 
their status during the previous two weeks. General guidelines for patients diagnosed with major 
depression suggest the following cut-off scores of depressive severity: minimal (0–13); mild 
(14–19); moderate (20–28); and severe (29–63). Convergent validity with the original Beck 
Depression Inventory (BDI-I; Beck, 1961) is reported at r = .93 and r = .71 with the Hamilton 
Psychiatric Rating Scale for Depression; its internal consistency is excellent, α = .91 among 
psychiatric outpatients, α = .93 among undergraduate students (Harris & D’Eon, 2008). 
Clinically significant change is generally considered to be reflected by a change in scores by nine 
points (Jacobson & Truax, 1991).  
 Pain-related Fear and Anxiety. Patients were provided a self-administered instrument 
designed to assess pain-related anxiety and fear. The Pain Anxiety Symptom Scale (PASS) is a 
40-item scale that measures the fear of pain across cognitive, behavioral, and physical domains 
(McCracken, Zayfert, & Gross, 1992). The items load onto four subscales: Fearful appraisal (a 
measure of fearful cognitions and negative expectancies related to pain), Cognitive anxiety 
(racing thoughts and impaired concentration related to pain), Physiological anxiety (somatic 
responses to pain), and Escape and avoidance (overt behavioral responses intended to reduce or 
eliminate pain). Questions are answered on a 7-point Likert scale ranging from never (0) to 
always (6), and the internal consistency is good with a Cronbach’s alpha for the entire instrument 
at .94. Its construct validity has been established by its moderate correlations with other anxiety 
scales. PASS subscale scores have been found to significantly correlate with measures of trait 
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anxiety (McCracken, Zayfert, & Gross, 1992). PASS scores have also been shown to be 
negatively correlated with physical assessments of range of motion and positively correlated with 
ratings of fear during these assessments (McCracken & Gross, 1995). PASS scores have also be 
found to be related to behavioral measures of disability and patient reports of fear of movement. 
Higher scores indicate greater anxiety responses. While clinical use is built around patients’ 
particular subscale scores as treatment targets, for the purpose of this study, scores reported are 
patients’ overall percentile ranks (compared with normative data provided by the test publisher). 
As a patients’ levels of pain related anxiety and fear of movement can be compared to that of 
other pain patients, scores above the 90th percentile have been characterized as a “significantly 
unhelpful level of anxious responding (McCracken & Gross, 1993).  
Perceived Ability to Self-manage Pain. Patients were assessed for their confidence in 
ability to perform specific tasks, engage in meaningful activities, and cope in spite of their pain, 
using the Pain Self Efficacy Questionnaire (PSEQ) (Nicholas, 2007). The PSEQ is a 10 item 
scale that reflects an individual’s beliefs about their capacity to manage their pain. It is 
considered useful as a screening instrument to gauge a person’s ability to benefit from pain 
management programs and high PSEQ scores are strongly associated with clinically significant 
functional gains in treatment (Nicholas, 2007). Scores cut-offs of 40 have been found to be 
associated with maintained treatment gains at 6-12 months, while scores of 30 or below suggest 
difficulty in maintaining treatment gains and greater likelihood of ongoing disability. Questions 
are answered on a 7-point Likert scale ranging from “not at all confident” (0) to “complete 
confident (6), and include such questions as “I can enjoy things despite the pain,” and “I can do 
most household chores despite the pain.” Internal consistency is excellent, with Cronbach’s alpha 
calculated at 0.92.  Validity was assessed through analysis of the factor structure and 
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examination of the PSEQ’s correlation with other validated measures and was found to be 
strong. The PSEQ has been found to be a strong predictor of functional outcomes from chronic 
pain treatment (Strong, 2002).  
Perceived Disability. Participants were provided a functional assessment to evaluate the 
degree of disability they experience related to their pain. The Perceived Disability Questionnaire 
(PDQ) (Anagnostis, Gatchel, and Mayer, 2004)  is a 15 item instrument that yields a score from 
0 – 150, and is designed for a wide range of musculoskeletal disorders rather than simply chronic 
low back pain. Test-retest reliability coefficients range from .94 to .98, and internal consistency 
is measured through Cronbach’s alpha of .96. Construct validity is also regarded to be excellent 
as the measure is highly correlated with two other highly validated measures, including the 
Oswestry and SF-36 (Anagnostis et al., 2004). Higher intake scores on the PDQ are associated 
with decreased return-to-work retention, and higher scores post treatment are associated with 
decreased return to work rates, decreased work retention (staying at the job), and increased 
percentages of seeking healthcare from a new provider (Gatchel et al, 2006).  Additionally, PDQ 
scores can be broken down into three categories: Mild/Moderate (0-70); Severe (71-100); and 
extreme (101-150).  This breakdown has been found to be predictive of work and health-related 
outcomes such as return to work, work retention, and healthcare utilization (Gatchel et al, 2006).   
It should be noted that the measures used to evaluate treatment outcome herein were not 
chosen by the clinic for their research, but rather their clinical value.  The clinic in which the 
treatment is conducted has determined that the measures they use to assess their patients at intake 
and discharge (aside from BMI) provide them the most useful clinical data regarding the 
emotional status of their patients, potential targets for treatment, suitability for treatment, and 
prediction of functioning post-treatment (C. Buist, Clinic Director, personal communication, July 
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2011). The particular measures utilized in this study were chosen by this researcher because they 
contained the most complete data (pre and post treatment) on each participant, as some other 
measures related to attitudes and coping skills were only provided at intake.  It was originally 
proposed that measures of cardiovascular fitness, flexibility, and functional capacity would be 
used to objectively evaluate physical outcomes of treatment. However, the data collected by the 
program simply noted “Improved fitness” and “Improved flexibility” as part of its outcome data. 
There was no information provided to indicate what “improved” ratings were based upon or to 
what amount of clinical change differentiated improved from not improved.  Further, there was 
little variance in these scores in the treatment outcomes data, as almost all patients that had 
completed the program were rated as having improved their flexibility and functional capacities 
(lift/carry, sitting and standing tolerances, etc.). This data was considered to add little 
interpretable data, and was therefore not considered for analysis. 
Intervention 
Prior to treatment, patients underwent a rigorous one-day assessment evaluation that 
included a medical and neurological evaluation, including medication review performed by 
registered nurses and physicians; physical ability testing performed by licensed physical 
therapists; functional capacity evaluation performed by licensed occupational therapists; 
vocational consultation by a vocational counselor; and psychological assessment performed by 
licensed clinical psychologist.  As part of this intake evaluation, participants completed self-
report measures that assessed the various dimensions of their subjective and objective response 
to chronic pain. 
The specific patient demographic and medical variables collected through clinical 
interview and intake questionnaires included age, gender, ethnicity, height/weight, mechanism of 
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injury, morphine dose equivalence (MSEQ), date of injury, injury-treatment interval, and 
insurer/referral source (see Appendix A for patient intake packet). Specific pain and disability 
information were gathered through a modified McGill Pain Inventory (Melzack, 1975), which 
evaluated the intensity, location, affective, and sensory qualities of their pain. Patients were also 
evaluated with a psychosocial assessment interview that focused on current symptoms, the 
history of treatment, psychosocial background, and the impact of chronic pain on the client’s life. 
The psychological battery consisted of symptom inventories and pain specific measures, 
including the Beck Depression Inventory (BDI-II), Pain Anxiety Symptom Scale (PASS), 
Chronic Pain Coping Inventory (CPCI), Survey of Pain Attitudes (SOPA), Pain Self-Efficacy 
Questionnaire (PSEQ), and Perceived Disability Questionnaire (PDQ). Treatment success is 
partially gauged by the amount of change from pre- to post-treatment on these self-report 
measures. 
 The discharge process consisted of a medical review, physical examination, tests of 
functional tolerances and physical abilities, and re-admittance five of the specific self-report 
measures (NRS, BDI-II, PASS, PSEQ, and PDQ). Following the completion of discharge 
reports, treatment outcome information is compiled and entered into medical records by clinical 
and administrative staff, and also entered into an outcome database by the quality assurance 
director.  
Treatment consisted of an intensive 20-day program multidisciplinary pain-management 
program led by a team of physicians, nurses, vocational counselors, physical therapists, 
occupational therapists, clinical psychologists, and graduate students. Patients were treated on an 
outpatient basis, with local patients staying at home and patients from over 25 miles away 
staying at a nearby hotel arranged by the program and paid for by their worker’s compensation 
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system. All patients attended an 8-hour per day structured treatment program, and any absences 
were made up for by adding additional treatment days. 
While treatment plans were individualized based upon the patients’ particular injuries, the 
focus was upon functional restoration rather than elimination of pain. Daily treatment 
components included: one-hour group therapy sessions for instruction in pain management, 
stress management, and coping skills; one-hour psychoeducation sessions related to 
physiological and psychological bases of pain, medication use, nutrition, worker’s compensation 
systems, and behavior change principles. Additional group sessions were related to improved 
body mechanics, mastering activities of daily living, increasing functional tolerances, and 
relaxation training. All patients received ongoing individual biofeedback training, cognitive-
behavioral therapy, and vocational counseling. Patients using narcotics had their medications 
evaluated on an individual basis, and were tapered off (or lowered) during the course of the 
program. Patients also participated in 3 hours of daily stretching, physical therapy, and 
occupational therapy classes that included individualized exercise quotas, therapeutic massage, 
thermal modalities, TENS, and assistive or orthotic devices.  Functional restoration focused upon 
improving patients’ sitting and standing tolerances, walking endurance, lift and carry capacity, 
and improved range of motion, balance, and ergonomic skills.  
Procedures 
Prior to participating in the intake assessment, patients were provided an informed 
consent document requiring their signature to allow any information gathered at intake, 
treatment, discharge, and follow-up to be used for any future research. Patients were not required 
to sign the informed consent as a requirement for treatment and only clients who provided 
consent had data available for evaluation in this study. Following approval of this study’s 
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proposal, permission was obtained from both the pain clinic’s Clinical Director and Privacy 
Officer, and Pacific University’s Institutional Review Board to retrospectively gather BMI data 
from the electronic patient medical record.  
After IRB approval was granted, a copy of the company’s outcomes database was 
created, and patient height and weight data gathered from the medical records was added to each 
patient’s record. The height and weight of each patient was the only variable of interest not 
typically extracted but was gathered from EMR and added to the data set for each patient 
sampled, serving as the calculation for patient BMI. All other variables of interest (scores on 
intake/outcome variables) had previously been compiled within a database maintained by the 
Quality Control department at PRA. These scores were verified against original clinical 
assessment reports, and several corrections were made to the scores reported in the company 
database. Following completion of the database with all variables of interest, each patient record 
was assigned a unique identifying number and subsequently all identifiable information was 
deleted (name and birthday). This de-identified database was saved as a password-protected 
encrypted file to a laptop for the researcher’s analysis.  
Data Screening and Preliminary Analysis 
Of 272 individual patients who were admitted to the clinic during the time period under 
consideration (2009 – 2011), 34 patients (12.5%) did not complete at least 17 days of the 20-day 
program, and these records were eliminated from consideration as it was not considered that they 
would have adequately engaged in the full program. 9 (3.3%) patient records did not include 
height and/or weight information, making BMI calculation impossible, and these records were 
also eliminated from the sample. Lastly, 8 (2.9%) patient records did not include scoring data 
from intake or discharge measures, and these records were also eliminated from the sample, for a 
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total of 51 records (18.8%), leaving 221 patient records for primary analysis.  Of the 34 
treatment dropouts, BMI was available from 26 participants (76%). Mean BMI of this treatment 
dropout sample was 31, and 65% (n = 17) met criteria for obesity with BMIs ≥ 30. Of the total 
sample, 14.4% of obese participants dropped out of treatment whereas 6.6% of non-obese 
participants failed to complete treatment (see Results section for analysis of this dropout rate).  
A review of the data was completed to ensure accuracy and completeness, and  a 
preliminary analysis screened all variables of interest using the SPSS 21.0 statistics program to 
ensure accuracy of data entry, screen for missing values and outliers, and evaluate normality of 
distributions. All scores on variables of interest were verified against the original clinical intake 
and discharge reports, and several corrections were made to the scores originally recorded in the 
clinic’s outcome database. The accuracy of data entry was completed by visually inspecting the 
data file to determine if any overtly inconsistent scores were present on any of the variables, in 
addition to reviewing the SPSS descriptive output for minimum and maximum scores. In order to 
address the assumptions of repeated measures ANOVA, the distribution of outcome scores at 
pre-and post-treatment were grouped according to weight status (Obese and Non-Obese) and 
examined for the presence of outliers through visual inspection of histograms and box-plots for 
pre-and post-treatment Pain, BDI, PASS, PSEQ, and PDQ raw scores. In the event an extreme 
outlier was determined by interquartile range, the score was evaluated for the number of standard 
deviations it lay from the mean.  
There were six extreme outliers found in the Non-Obese group pre-treatment Pain scores 
based on interquartile range. An examination of the distribution of these scores indicated that all 
scores fell within three standard deviations. Examination of the participants’ raw data verified 
that these outlier scores were not the result of entry errors and that the participants who provided 
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these scores were valid members of the participant population. Therefore, these outliers were 
included in the data analysis.  There were no extreme outliers found for Obese group Pain pre-
treatment scores based on interquartile range and all scores fell within three standard deviations 
of the mean.  
There were no extreme outliers found for Non-Obese group post-treatment Pain scores 
based on interquartile range and all scores fell within three standard deviations of the mean. 
There was one extreme outlier found in the Obese group post-treatment Pain scores based on 
interquartile range, and an examination of the distribution indicated that all scores fell within 
three standard deviations of the mean.  Examination of this participant’s raw data verified that 
this score was not the result of entry error and that the participant who provided this score was a 
valid member of the participant population, and thus was included in the data analysis.  
There were no extreme outliers found for Non-Obese group BDI pre-treatment scores 
based on interquartile range and all scores fell within three standard deviations of the mean. Two 
extreme outliers were present within the Obese group BDI pre-treatment scores based on 
interquartile range and an examination of the distribution indicated that these scores fell within 
three standard deviations of the mean.  Examination of these participants’ raw data verified that 
these scores were not the result of entry errors and that the participants who provided these 
scores were valid members of the participant population, and thus were included in the data 
analysis. 
There were three extreme outliers found for Non-Obese group BDI post-treatment scores 
based on interquartile range; an examination of the distribution indicated that these scores (z = 
3.29, z = 3.39, z = 3.39) fell slightly outside of three standard deviations of the mean. 
Examination of these participants’ raw data verified that these scores were not the result of entry 
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errors and that the participants who provided these scores were valid members of the participant 
population, and thus were included in the data analysis. In addition, inclusion of these scores was 
deemed relevant to the study’s assumption that chronic pain patients would show a wide variance 
in response to treatment.  
Two extreme outliers were found within the Obese group BDI post-treatment scores 
based on interquartile range and an examination of the distribution indicated that these scores (z 
= 3.29, z = 3.39) fell slightly outside of three standard deviations of the mean.  Examination of 
these participants’ raw data verified that these scores were not the result of entry errors and that 
the participants who provided these scores were valid members of the participant population, and 
thus were included in the data analysis. 
There were no extreme outliers on PASS pre- or post-treatment scores for either group 
based on interquartile range. An examination of the distribution indicated that all scores fell 
within three standard deviations of the mean. 
Two extreme outlier scores were found on the PSEQ pre-treatment scores for the Non-
obese group based on interquartile range, however an examination of the distribution indicated 
that all scores fell within three standard deviations of the mean. There were no extreme outlier 
scores found for the Obese groups PSEQ pre-treatment scores. There were no extreme outliers 
on PSEQ post-treatment scores for either group based on interquartile range. An examination of 
the distribution indicated that all scores fell within three standard deviations of the mean. 
There were two extreme outlier scores found on the PDQ pre-treatment for the Non-
obese group and one extreme outlier found in the PDQ pre-treatment for the Obese group, based 
on interquartile range; an examination of the distribution indicated that all scores fell within three 
standard deviations of the mean. Examination of the patients’ raw data indicated that these scores 
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were not the result of data entry and these participants were valid members of the patient 
population and were thus included for analysis.  There were no extreme outliers found in the 
PDQ post-treatment scores for the Non-obese group.  There was one extreme outlier found in the 
PDQ post-treatment scores for the Obese group, based on interquartile range, however an 
examination of the distribution indicated that all scores fell within three standard deviations of 
the mean. Examination of the patient’s raw data indicated that this score was not the result of 
data entry and this participant was a valid member of the patient population and was thus 
included for analysis.   
Further preliminary analysis of each dependent variable within each group (Obese/None 
Obese) was conducted to ensure that scores met assumptions for normality (See Table 2 for 
Skewness and Kurtosis of pre-treatment and post-treatment scores on all variables). Though 
some distributions of the variables (e.g., BDI post-treatment) were moderately skewed and/or 
kurtotic, normality was assumed as the values were not +/- 2.0. Tests for equality of error 
variance and homogeneity of variance-covariance matrices will be addressed within the Results 
section.  
Table 2 
Distribution of Scores on Pre and Post-Treatment Dependent Variables 
 
 Pre-Treatment  Post Treatment 
      
 
Measure 
Obese 
 
Skewness    Kurtosis 
Non-Obese 
 
Skewness  Kurtosis 
 
 
Obese 
 
Skewness   Kurtosis 
Non-Obese 
 
Skewness  Kurtosis 
 
Pain .017 -.600 -.195 -.247  -.355 .231 -.200 -.316 
BDI .348 .014 .398  - .451  1.075 1.409 1.147 1.516 
PASS -.172 -1.112 .264 -1.022  .421 -1.031 .565 -.906 
PSEQ .215 -.136 .092 -.219  -.114 -.716 -.249 -.380 
PDQ -.562 .264 -.542 -.167  -.830 .503 -.565 -.556 
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To examine mean change scores between groups, 5 additional variables (e.g., Change in 
Pain, Change in Depression, etc.) were created by subtracting the pre-treatment raw score from 
the post-treatment raw score on each variable of interest.  In order to address the assumptions of 
Independent samples t-test, the distribution of change scores were grouped according to weight 
status (Obese and Non-Obese) and examined for the presence of outliers through visual 
inspection of histograms and box-plots for Change in Pain, Depression, Anxiety, Self-efficacy, 
and Disability. In the event an extreme outlier was determined by interquartile range, the score 
was evaluated for the number of standard deviations it lay from the mean, and whether the score 
was a result of error.  
There were eleven extreme outliers found for Non-Obese group Change in Pain scores 
based on interquartile range; an examination of the distribution indicated that only one of these 
scores (z = 3.28) fell slightly outside of three standard deviations of the mean. Examination of 
this participant’s raw data verified that this score was not the result of entry error and that the 
participant who provided this score was a valid member of the participant population, and thus 
was included in the data analysis. In addition, inclusion of this score was deemed relevant to the 
study’s assumption that chronic pain patients would show a wide variance in response to 
treatment.  
There were six extreme outliers found for Obese group Change in Pain scores based on 
interquartile range; an examination of the distribution indicated that only one of these scores (z = 
3.31) fell slightly outside of three standard deviations of the mean. Examination of this 
participant’s raw data verified that this score was not the result of entry error and that the 
participant who provided this score was a valid member of the participant population, and thus 
was included in the data analysis. In addition, inclusion of this score was deemed relevant to the 
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study’s assumption that chronic pain patients would show a wide variance in response to 
treatment. 
There were four extreme outliers found for Non-obese group Change in Depression 
scores based on interquartile range; an examination of the distribution indicated that none of 
these scores fell outside of three standard deviations from the mean. Examination of these 
participants’ raw data verified that these scores were not the result of entry error and that the 
participants who provided these scores were valid members of the participant population, and 
thus were included in the data analysis.  
There was one extreme outlier found for Obese group Change in Depression scores based 
on interquartile range; an examination of the distribution indicated that this score (z = 3.62) fell 
slightly outside of three standard deviations from the mean. Examination of this participant’s raw 
data verified that this score was not the result of entry error and that the participant who provided 
this score was a valid member of the participant population, and thus was included in the data 
analysis. 
There were six extreme outliers found for Non-obese group Change in Anxiety scores 
based on interquartile range; an examination of the distribution indicated that none of these 
scores fell outside of three standard deviations from the mean. Examination of these participants’ 
raw data verified that these scores were not the result of entry error and that the participants who 
provided these scores were valid members of the participant population, and thus were included 
in the data analysis.  There were no extreme outliers found for the Obese group’s Change in 
Anxiety scores and all scores fell within three standard deviations from the mean.  
There were no extreme outliers found for the Non-obese group’s Change in Self-Efficacy 
scores and all scores fell within three standard deviations from the mean.  There was one extreme 
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outliers found for the Obese group’s Change in Self-Efficacy scores based on interquartile range; 
an examination of the distribution indicated that this score (z = 3.08) fell slightly outside of three 
standard deviations from the mean. Examination of these participants raw data verified that these 
scores were not the result of entry error and that the participants who provided these scores were 
valid members of the participant population, and thus were included in the data analysis.   
There were two extreme outliers found for Non-obese group Change in Disability scores 
based on interquartile range; an examination of the distribution indicated that none of these 
scores fell outside of three standard deviations from the mean. Examination of these participants’ 
raw data verified that these scores were not the result of entry error and that the participants who 
provided these scores were valid members of the participant population, and thus were included 
in the data analysis.  There were no extreme outliers found for the Obese group’s Change in 
Disability scores and all scores fell within three standard deviations from the mean. 
Further preliminary analysis of the change scores within each group (Obese/None Obese) 
was conducted to ensure that scores met assumptions for normality (See Table 3 for Skewness 
and Kurtosis of change scores on all variables). Though some distributions of the variables (e.g., 
BDI post-treatment) were moderately skewed and/or kurtotic, normality was assumed as the 
values were not +/- 2.0. Equality of variances was addressed through Levene’s Test, and none 
were found to be significant. Thus, although the Obese and Non-obese groups were of unequal 
size, results are reported with equal variances assumed. 
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Table 3 
Distribution of Scores on Change Variables 
 
 
Measure 
Obese 
 
Skewness      Kurtosis 
Non-Obese 
 
Skewness     Kurtosis 
 
 
 
Change in Pain .061 1.483 -.205 1.068  
Change in BDI -.445 .350 -.514 .946  
Change in PASS -.304 -.397 -.565 -.047  
Change in PSEQ .493 -.091 .588 -.093  
Change in PDQ -.175 -.531 -.786 .436  
 
Though some of the score distributions were moderately skewed or kurtotic, normality 
was assumed because none of the values were greater than ± 2.0;  as normality could be 
assumed, it was determined that an independent samples t-test would be appropriate for 
statistical analysis of these change scores. Scores on the different measures were independent 
from one another and therefore the assumption of independence was met.  
To test the hypothesis (1) that obesity would predict differences in response to treatment, 
such that participants with BMIs ≥ 30 (obese) would have higher rates of treatment drop-out than 
participants with BMIs < 30 (non-obese), a chi-square test of independence was performed to 
compare the proportion of cases that occurred in each group.  
Primary clinical analyses examined the effects of treatment and obesity on MCPM 
outcomes, specifically measures of pain intensity, depression, anxiety, self-efficacy, and 
disability. To investigate these issues, the sample of participants was grouped according to their 
weight status: obese or non-obese; this between-subjects factor was labeled Obesity. In addition, 
each participant was measured before and after treatment for their level of pain intensity, 
creating a single within-subjects factor, labeled Time.  
To evaluate Hypothesis 2, a series of mixed-model repeated-measure ANOVAs were 
conducted to evaluate the within-subjects main effect for Time to determine if treatment 
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influenced the participants’ levels of pain intensity, depression, anxiety, self-efficacy, and 
disability (i.e., did the mean pain rating change from pre-treatment to post-treatment).  To 
address Hypothesis 3, the interaction effect from the mixed model ANOVA, Time x Obesity, was 
examined to determine if group differences on the outcome measures varied across time.  
 To address Hypotheses 4 – 8, the between-subjects main effects for Obesity, the mixed-
model repeated-measure ANOVAs were evaluated to determine if obesity influenced participant 
levels of pain intensity, depression, anxiety, self-efficacy, and disability (i.e., did obese 
participants have different mean pain intensity ratings than non-obese participants).  
To examine mean change scores between groups (Hypotheses 9 – 13), 5 additional 
variables (e.g., Change in Pain, Change in Depression, etc.) were created by subtracting the pre-
treatment raw score and the post-treatment raw score on each variable of interest. A series of 
independent-samples t-tests were conducted to evaluate whether the mean amount of change 
from pre-treatment to post-treatment differed between obese and non-obese participants on each 
outcome variable. The independent variable was the weight status of each group, with two levels 
Obese and Non-obese. The dependent variables were the participants’ change scores on 
measures of pain, depression, anxiety, self-efficacy, and disability. To reduce the probability of 
committing a Type I error due to multiple pairwise comparisons within the mixed ANOVA and 
Independent t-tests, a Bonferroni correction was performed to each set of analyses. As there were 
5 pairwise comparisons within each analysis, the alpha was set at 0.01 ( α = 0.05/5). The 
Bonferroni was chosen in this instance as it is a general, though conservative, method of 
evaluating multiple pairwise comparisons (Green & Salkind, 2008).    
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Results 
Preliminary Analyses 
Demographics comparisons using chi-square and independent samples t-test results 
showed no statistically significant differences between obese and non-obese groups. See Table 4 
for more information related to demographic comparisons.  
Table 4  
Demographics Comparisons Between Obese And Non-Obese Groups. 
 
 Obese (N = 96)  Non-obese (N = 125) 
        
 
Demographic 
 
N 
 
Mean (SD) / % 
  
N 
 
Mean (SD) / % 
 
 
  
(P) 
 
Age 96 45.27 (10.03)  125 44.45 (10.05)  0.55 
Gender 
     Male 
     Female 
 
66 
30 
 
68.8% 
31.3% 
   
79 
46 
 
63.2% 
36.8% 
  0.47 
Race 
     Caucasian 
     Other 
 
81 
15 
 
84.4% 
15.6% 
   
106 
19 
 
84.8% 
15.2% 
  1.00 
Pain duration (months) 96 40.59 (39.74)  125 46.78 (56.79)  0.36 
Morphine equivalency (pretreatment) 75 58.30 (71.86)  78 76.40 (70.81)  0.12 
Average pain intensity (pre treatment 96 6.37 (1.51)  125 6.33    (1.44)  0.85 
Mechanism of Injury 
    Upper Body  
    Lower Extremity 
    Lumbar 
    Multiple 
 
29 
9 
45 
13 
 
30.2% 
9.4% 
46.9% 
13.5% 
   
30 
10 
61 
24 
 
24.0% 
8.0% 
48.8% 
19.2% 
  0.58 
 
 

 Chi square analyses and independent samples t-tests 
 
As previously noted, 14.4% of obese participants dropped out of treatment whereas 6.6% 
of non-obese participants failed to complete treatment. Drop-out rates between groups were 
compared using a Chi-Square Test of Independence (with Yates Continuity Correction), which 
indicated no connection between obesity and attrition, χ2 (1, N = 239) = .99, p = .32, Φ = .08.  It 
was expected that obese patients would have higher treatment drop out rates than non-obese 
patients. This finding failed to support this hypothesis (1).   
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Primary Clinical Outcomes. 
The following results are presented according to each outcome domain tested. The means 
and standard deviations of each Pre- and Post-test variable are presented in Table 5. The main 
and interaction effects from the mixed-model ANOVA are presented in Table 6.  
 
Table 5 
Means and Standard Deviations on Outcome Variables Pre- and Post- Treatment by Obesity 
 
 Pre-Treatment  Post Treatment 
      
 
Measure 
Obese 
N = 96 
M (SD) 
Non-Obese 
N = 125 
M (SD) 
 
 
Obese 
N = 96 
M (SD) 
Non-Obese 
N = 125 
M (SD) 
 
Pain 6.37 (1.51) 6.33 (1.45)  5.57 (1.74) 5.58 (1.54) 
BDI 22.42 (10.78) 20.78 (11.29)  14.11 (9.89) 13.90 (10.17) 
PASS 48.28 (23.89) 43.02 (25.90)  35.08 (25.19) 33.06 (24.89) 
PSEQ 24.88 (10.97) 25.34 (11.04)  37.04 (13.21) 36.66 (12.17) 
PDQ 99.12 (19.07) 97.90 (19.00)  83.68 (23.87) 86.00 (25.13) 
 
 
Pain Intensity 
A mixed-model ANOVA was conducted to evaluate the effect of treatment and obesity 
on a measure of average pain intensity to determine if changes in pain intensity following 
treatment varied as a function of weight status. 221 participants rated their average pain intensity 
on a numerical rating scale of 0 - 10 at both pre-treatment and post-treatment; these scores were 
grouped according to the participants’ weight status, Obese and Non-Obese. The dependent 
variable was participants’ pain ratings, while the two factors were Time and Obesity. An 
interaction effect (Time x Obesity) examined whether or not changes in pain ratings varied as a 
function of obesity (Hypothesis 2). A within-subjects main effect for Time was examined to see 
if participants’ mean pain ratings changed from pre-treatment to post-treatment while a between 
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subjects main-effect for Obesity evaluated whether obese participants had different (greater) 
mean pain intensity ratings across time periods than non-obese participants (Hypothesis 3). The 
results of Levene’s test for the pretreatment pain rating, F(1,219) = .51 p = .475 and post-
treatment pain rating F(1,219) = .24, p =  .236 were not significant, indicating that the error 
variance in the dependent variable was equivalent across groups. Box’s Test for Equality of 
Covariance Matrices was not significant (p = .423), therefore homogeneity of variance-
covariance was assumed.  
The Time x Obesity interaction effect was not significant, Wilks’ Λ = 1.00, F(1, 219) = 
.05, p = .817, partial η2 < .001, indicating that less than .1% of the variance could be accounted 
for by an interaction between time and obesity, a very small effect size. The Time main effect 
was significant, Wilks’ Λ = .81, F(1, 219) = 51.42, p < .001, partial η2 = .19, with both groups 
showing reductions in pain intensity, and indicating that 19% of the variance could be accounted 
for by time, a large effect size. The results indicated participants showed significant reductions 
from pre- to post-test on pain ratings scores (M = -.78, SE =.11, 95% CI [-.99, -.56]). The main 
effect comparing groups of participants was not significant, F(1,219) = .01, p = .944, partial η2 < 
.001, suggesting no difference in the pain intensity ratings between obese and non-obese 
participants. It was expected that participants would demonstrate significant reductions in pain 
intensity from pre- to post-treatment, and this finding supports that hypothesis (2). It was 
expected that these reductions would vary according to weight status, and this finding failed to 
support that hypothesis (3). Lastly, it was expected that obese and non-obese groups would differ 
in average pain intensity, and this finding failed to support that hypothesis (4) (see Figure 2). 
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Figure 2. Reductions in pain intensity from pre- to post-treatment between obese and non-obese 
participants. 
 
An independent-samples t-test was conducted to evaluate the hypothesis (9) that non-
obese participants would show greater change in pain scores from pre- to post-treatment than 
obese participants. The test was not significant, t(219) = .23, p = .817. Obese participants’ 
Change in Pain scores (M = -.80, SD = 1.55) were comparable with Non-obese participants 
Change in Pain scores (M =  -.75, SD = 1.63). The 95% confidence interval for the difference in 
means ranged from -.38 to .48. The eta square effect size was very small (η2 < .001), indicating 
that less than .1% of the variability in change in pain ratings was accounted for by whether or not 
the participant was obese. Based on these results, obese participants’ Change in Pain from pre to 
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post-treatment do not differ from those of Non-obese participants, and thus this hypothesis was 
not supported.  
As noted, the overall mean change in pain was less than one point (M = -0.77, SD = 1.59, 
95% CI [-.99,  -.56]), though Change in Pain ratings ranged from a reduction of 6 points to an 
increase of 4.5 points. The most frequent change score was zero (n =48, 21.7%), and 57% of 
patients experienced change of 1 point or less on the 10 point scale; 48 participants (21.7%) 
reported a reduction in pain ratings by two points or more.  65% of participants rated their pain 
as a 6/10 or worse at intake, while 50% rated their pain as a 6/10 or worse at discharge. At 
discharge, 13 participants (5.9%) reported their pain had increased by two points or more. 10% 
(n = 22) of patients completed treatment with pain intensity ratings of 3.5/10 or less.  
 Depression 
A mixed-model ANOVA was conducted to evaluate the effect of treatment and obesity 
on a measure of average depression scores to determine if changes in depression following 
treatment varied as a function of weight status. 221 participants completed the BDI – II, rating 
their depression on a numerical rating scale of 0 - 63 at both pre-treatment and post-treatment; 
these scores were grouped according to the participants’ weight status, Obese and Non-Obese. 
The dependent variable was participants’ depression scores, while the two factors were Time and 
Obesity. An interaction effect (Time x Obesity) examined whether or not changes in depression 
scores varied as a function of obesity (Hypothesis 2). A within-subjects main effect for Time was 
examined to see if participants’ mean depression scores changed from pre-treatment to post-
treatment while a between subjects main-effect for Obesity evaluated whether obese participants 
had different (greater) mean depression scores across time periods than non-obese participants 
(Hypothesis 3). The results of Levene’s test for the pretreatment depression score, F(1,219) = 
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2.041, p = .154 and post-treatment depression score F(1,219) = .03, p = .866 were not 
significant, indicating that the error variance in the dependent variable was equivalent across 
groups. Box’s Test for Equality of Covariance Matrices was not significant (p = .582), therefore 
homogeneity of variance-covariance was assumed.  
The Time x Obesity interaction effect was not significant, Wilks’ Λ = 1.00, F(1, 219) = 
1.09, p = .297, partial η2  = .005, indicating that less than .5% of the variance could be accounted 
for by an interaction between time and obesity, a very small effect size. The Time main effect 
was significant, Wilks’ Λ = .64, F(1, 219) = 124.72, p < .001, partial η2 = .36, with both groups 
showing reductions in depression, and indicating that 36% of the variance could be accounted for 
by time, a large effect size. The results indicated participants showed significant reductions from 
pre- to post-treatment on depression scores (M = -7.59, SE =.68, 95% CI [-8.93, -6.25]). The 
main effect comparing groups of participants was not significant, F(1,219) = .53, p = .467, 
partial η2 = .002, suggesting little difference in the depression scores between obese and non-
obese participants. It was expected that participants would demonstrate significant reductions in 
depression from pre- to post-treatment, and this finding supports that hypothesis (2). It was 
expected that these reductions would vary according to weight status, and this finding failed to 
support that hypothesis (3). Lastly, it was expected that obese and non-obese groups would differ 
in average pain intensity, and this finding failed to support that hypothesis (5) (see Figure 3). 
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Figure 3. Reductions in depression scores from pre- to post-treatment between Obese and Non-
obese participants.  
 
An independent-samples t-test was conducted to evaluate the hypothesis (10) that non-
obese participants would show greater change in depression scores from pre- to post-treatment 
than obese participants. The test was not significant, t(219) = 1.20, p = .231. Obese participants’ 
Change in Pain scores (M = -8.30, SD = 10.60) were comparable with Non-obese participants 
Change in Pain scores (M =  -6.66, SD = 9.70). The 95% confidence interval for the difference 
in means ranged from -1.06 to 4.35. The eta square effect size was very small (η2 < .001), 
indicating that less than .1% of the variability in change in depression scores was accounted for 
by whether or not the participants were obese. Based on these results, obese participants’ Change 
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in Depression from pre to post-treatment do not differ from those of Non-obese participants, and 
thus this hypothesis was not supported.  
As noted, the overall mean reduction in BDI score was 7 points (M = -7.37, SD = 10.11, 
95% CI [-8.71, -6.03]), with changes in depression ratings ranging from a decrease of 44 points 
to an increase of 21 points. The most frequent change score was zero (n =26, 11.8%), though 
65.2% (n = 144) of participants experienced a change of 5 points or more. 36 participants 
(21.7%) reported a reduction in depression scores of at least 10 points, while 8 participants 
(3.6%) reported their depression scores had increased by 10 points or more.  
 Pain-Related Fear and Anxiety 
A mixed-model ANOVA was conducted to evaluate the effect of treatment and obesity 
on a measure of Pain-related fear and anxiety (PASS) scores to determine if changes in anxiety 
following treatment varied as a function of weight status. 221 participants completed the PASS, 
which rates their anxiety on a scale of 1 – 100 at both pre-treatment and post-treatment; these 
scores were grouped according to the participants’ weight status, Obese and Non-Obese. The 
dependent variable was participants’ anxiety scores, while the two factors were Time and 
Obesity. An interaction effect (Time x Obesity) examined whether or not changes in anxiety 
scores varied as a function of obesity (Hypothesis 2). A within-subjects main effect for Time was 
examined to see if participants’ mean anxiety scores changed from pre-treatment to post-
treatment while a between subjects main-effect for Obesity evaluated whether obese participants 
had different (greater) mean anxiety scores across time periods than non-obese participants 
(Hypothesis 3). The results of Levene’s test for the pretreatment anxiety score, F(1,219) = 1.245, 
p = .266 and post-treatment anxiety score F(1,219) = .02, p = .901 were not significant, 
indicating that the error variance in the dependent variable was equivalent across groups. Box’s 
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Test for Equality of Covariance Matrices was not significant (p = .631), therefore homogeneity 
of variance-covariance was assumed.  
The Time x Obesity interaction effect was not significant, Wilks’ Λ = 1.00, F(1, 219) = 
1.08, p = .299, partial η2  = .005, indicating that less than .5% of the variance could be accounted 
for by an interaction between time and obesity, a very small effect size. The Time main effect 
was significant, Wilks’ Λ = .80, F(1, 219) = 55.14, p < .001, partial η2 = .20, with both groups 
showing reductions in anxiety, and indicating that 20% of the variance could be accounted for by 
time, a large effect size. The results indicated participants showed significant reductions from 
pre- to post-treatment on anxiety scores (M = -11.58, SE =1.60, 95% CI [-14.65, -8.50]). The 
main effect comparing groups of participants was not significant, F(1,219) = 1.46, p = .229, 
partial η2 = .007, suggesting little difference in the anxiety scores between obese and non-obese 
participants. It was expected that participants would demonstrate significant reductions in 
anxiety from pre- to post-treatment, and this finding supports that hypothesis (2). It was expected 
that these reductions would vary according to weight status, and this finding failed to support 
that hypothesis (3). Lastly, it was expected that obese and non-obese groups would differ in 
anxiety across time, and this finding failed to support that hypothesis (6) (see Figure 4). 
An independent-samples t-test was conducted to evaluate the hypothesis (11) that non-
obese participants would show greater change in anxiety scores from pre- to post-treatment than 
obese participants. The test was not significant, t(219) = 1.04, p = .299. Obese participants’ 
Change in Anxiety scores (M = -13.20, SD = 21.69) were comparable with Non-obese 
participants’ Change in Anxiety scores (M =  -9.95, SD = 23.91). The 95% confidence interval 
for the difference in means ranged from -2.90 to 9.39. The eta square effect size was very small 
(η2 = .005), indicating that .5% of the variability in change in anxiety was accounted for by 
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whether or not the participant was obese. Based on these results, obese participants’ Change in 
Anxiety from pre to post-treatment do not differ from those of Non-obese participants, and thus 
this hypothesis was not supported.  
 
Figure 4. Reductions in pain-related fear and anxiety scores from pre- to post-treatment between 
Obese and Non-obese participants.  
 
As noted, the mean reduction in PASS scores was approximately 11.5 percentile points 
(M = -11.36, SD = 22.98, 95% CI [-14.41, -8.32]), with changes in anxiety ratings ranging from a 
decrease of 75 percentile points to an increase of 40 percentile points. The median and modal 
change were -5.00 (n =28, 12.7%) though 107 participants (48.4%) reported a reduction in PASS 
scores of 10 percentile points or more. 39 participants (17.6%) reported their PASS scores 
increased by 10 percentile points or more. Though not previously hypothesized, it was noted that 
at intake 10 participants (4.5%) met the criterion for “problematic” extreme anxiety of 90th 
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percentile or higher, and at discharge, 3 participants (1.4%) met this criterion.  Due to the small 
number of participants, a Fisher’s Exact Test was conducted rather than a McNemar’s. The result 
indicated that this was a significant reduction in the number of participants with extreme ratings 
of PASS ≥ 90 following treatment, p < .001. 
 Self-efficacy 
A mixed-model ANOVA was conducted to evaluate the effect of treatment and obesity 
on a measure of Pain-related self-efficacy ratings (PSEQ) to determine if changes in self-efficacy 
following treatment varied as a function of weight status. 221 participants completed the PSEQ, 
rating their self-efficacy on a numerical rating scale of 0 to 60 at both pre-treatment and post-
treatment; these scores were grouped according to the participants’ weight status, Obese and 
Non-Obese. The dependent variable was participants’ self-efficacy scores, while the two factors 
were Time and Obesity. An interaction effect (Time x Obesity) examined whether or not changes 
in self-efficacy scores varied as a function of obesity (Hypothesis 2). A within-subjects main 
effect for Time was examined to see if participants’ mean self-efficacy scores changed from pre-
treatment to post-treatment while a between subjects main-effect for Obesity evaluated whether 
obese participants had different (lower) mean self-efficacy scores across time periods than non-
obese participants (Hypothesis 3). The results of Levene’s test for the pretreatment self-efficacy 
score, F(1,219) >.001, p = .994 and post-treatment self-efficacy score F(1,219) = 1.25, p = .265 
were not significant, indicating that the error variance in the dependent variable was equivalent 
across groups. Box’s Test for Equality of Covariance Matrices was not significant (p = .848), 
therefore homogeneity of variance-covariance was assumed.  
The Time x Obesity interaction effect was not significant, Wilks’ Λ = 1.00, F(1, 219) = 
.27, p = .608, partial η2  = .001, indicating that .1% of the variance could be accounted for by an 
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interaction between time and obesity, a very small effect size. The Time main effect was 
significant, Wilks’ Λ = .52, F(1, 219) = 203.56, p < .001, partial η2 = .48, with both groups 
showing increases in self-efficacy, and indicating that 48% of the variance could be accounted 
for by time, a very large effect size. The results indicated participants showed significant 
increases from pre- to post-treatment on self-efficacy scores (M = 11.74, SE =.82, 95% CI 
[10.12, 13.36]). The main effect comparing groups of participants was not significant, F(1,219) 
>.01, p = .978, partial η2 = .002, suggesting no difference in the self-efficacy scores between 
obese and non-obese participants. It was expected that participants would demonstrate significant 
increases in self-efficacy from pre- to post-treatment, and this finding supports that hypothesis 
(2). It was expected that these increases would vary according to weight status, and this finding 
failed to support that hypothesis (3). Lastly, it was expected that obese and non-obese groups 
would differ in average self-efficacy, and this finding failed to support that hypothesis (7) (see 
Figure 5). 
An independent-samples t-test was conducted to evaluate the hypothesis (12) that non-
obese participants would show greater change in self-efficacy scores from pre- to post-treatment 
than obese participants. The test was not significant, t(219) = -.51, p = .608. Obese participants’ 
Change in Self Efficacy scores (M = 12.17, SD = 12.38) were comparable with Non-obese 
participants scores (M = 11.32, SD = 11.94). The 95% confidence interval for the difference in 
means ranged from -4.09 to 4.35. The eta square effect size was very small (η2 = .001), 
indicating that .1% of the variability in change in self-efficacy was accounted for by whether or 
not the participant was obese. Based on these results, obese participants’ Change in Self Efficacy 
from pre to post-treatment did not differ from those of Non-obese participants, and thus this 
hypothesis was not supported.  
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Figure 5. Reductions in Pain-related self-efficacy scores from pre to post-treatment between 
Obese and Non-obese participants.  
 
As noted, the mean Change in Self-efficacy was approximately 11 points (M = 11.69, SD 
= 12.11, 95% CI [10.08, 13.29]), with change in self-efficacy ratings ranging from a decrease of 
13 points to an increase of 49 points. The most frequent change was 0.00 (n =35, 15.8%), and 
34.8% (n = 74) reported changes of 5 points or less. 111 participants (52.5%) reported an 
increase in PSEQ scores of 10 points or more, while 5 participants (2.3%) reported their self-
efficacy had decreased by 10 points or more.  At intake, approximately 70% of participants (n = 
155) scored 30 or less on the PSEQ, while only 10% (n = 22) scored 40 or above. After 
treatment, approximately 44% (n = 97) of participants scored at 40 or above, while 33% (n =  73) 
remained below the cutoff score of 30.  
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 Perceived Disability 
A mixed-model ANOVA was conducted to evaluate the effect of treatment and obesity 
on a measure of perceived disability (PDQ) scores to determine if changes in disability following 
treatment varied as a function of weight status. Only a subset of participants completed the PDQ 
as this measure was introduced towards the end of the sampling period  (n = 54, 24%). 
Participants completed the PDQ, rating their disability on a numerical rating scale of 0 - 150 at 
both pre-treatment and post-treatment; these scores were grouped according to the participants’ 
weight status, Obese and Non-Obese. The dependent variable was participants’ disability scores, 
while the two factors were Time and Obesity. An interaction effect (Time x Obesity) examined 
whether or not changes in disability scores varied as a function of obesity (Hypothesis 2). A 
within-subjects main effect for Time was examined to see if participants’ mean disability scores 
changed from pre-treatment to post-treatment while a between subjects main-effect for Obesity 
evaluated whether obese participants had different (lower) mean disability scores across time 
periods than non-obese participants (Hypothesis 3). The results of Levene’s test for the 
pretreatment disability score, F(1,52) > .01, p = .988 and post-treatment disability score F(1,52) 
= .32, p = .574 were not significant, indicating that the error variance in the dependent variable 
was equivalent across groups. Box’s Test for Equality of Covariance Matrices was not 
significant (p = .706), therefore homogeneity of variance-covariance was assumed.  
The Time x Obesity interaction effect was not significant, Wilks’ Λ =.99, F(1, 52) = .53, 
p = .471, partial η2  = .010, indicating that 1% of the variance could be accounted for by an 
interaction between time and obesity, a very small effect size. The Time main effect was 
significant, Wilks’ Λ = .62, F(1, 52) = 31.34, p < .001, partial η2 = .37, with both groups 
showing reductions in disability, and indicating that 37% of the variance could be accounted for 
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by time, a large effect size. The results indicated participants showed significant reductions from 
pre- to post-treatment on disability scores (M = -13.67, SE =2.44, 95% CI [-18.58, -8.77]). The 
main effect comparing groups of participants was not significant, F(1,52) = .53, p = .471, partial 
η
2
 = .010, suggesting little difference in the disability scores between obese and non-obese 
participants. It was expected that participants would demonstrate significant reductions in 
disability from pre- to post-treatment, and this finding supports that hypothesis (2). It was 
expected that these reductions would vary according to weight status, and this finding failed to 
support that hypothesis (3). Lastly, it was expected that obese and non-obese groups would differ 
in average perceived disability, and this finding failed to support that hypothesis (8) (see Figure 
6). 
 
 
Figure 6. Reductions in perceived disability scores from pre- to post-treatment between Obese 
and Non-obese participants. 
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An independent-samples t-test was conducted to evaluate the hypothesis (13) that non-
obese participants would show greater change in disability scores from pre- to post-treatment 
than obese participants. The test was not significant, t(52) = .73, p = .47. Obese participants’ 
Change in Disability scores (M = -15.44, SD = 15.56) were comparable with Non-obese 
participants Change in Disability scores (M =  -11.90, SD = 19.67). The 95% confidence interval 
for the difference in means ranged from -6.26 to 13.34. The eta square effect size was very small 
(η2 =.01), indicating that less than 1% of the variability in change in disability was accounted for 
by whether or not the participant was obese. Based on these results, obese participants’ Change 
in Disability from pre to post-treatment did not differ from those of Non-obese participants, and 
thus this hypothesis was not supported.  
As noted the mean reduction in PDQ rating was approximately 14 points (M = -13.54, SD 
= 17.81, CI 95% [-18.40, -8.68]), with change in disability ratings ranging from a decrease of 61 
points to an increase of 23 points. The most frequent change was 0.00 (n =5, 9.3%) and 22% (n 
= 12) reported changes of 5 points or less. However, 35.2% (n = 10) patients reported an 
decrease in PDQ scores of 20 points or more, while only 1 participant (2.3%) reported an 
increase in perceived disability by 20 points or more.   
Though not related to an original hypothesis, PDQ scores for the entire sample were 
further partitioned into distinct theoretical categories: Mild/moderate (scores 0-70); Severe 
(scores 71 – 100), and Extreme (scores 101-150), modeled after cut-off scores that have been 
shown to be predictive of work and health related outcomes (Gatchel et al., 2006).  At intake, out 
of 54 participants,  6 (11.1%) scored within the Mild/moderate range, 22 (40.7%) scored as 
Severe, and 26 (48.1%) scored in the Extreme range. At discharge, 16 (29.6%) participants 
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scored within the Mild/moderate range, 23 (42.6%) within the Severe, and 15 (27.8%) 
participants continued to score within the Extreme range of perceived disability.  
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Table 6 
Effects Of Time And Obesity On Multidisciplinary Chronic Pain Management Treatment Outcomes. *  
 
 Pre-Treatment Post Treatment Main Effect (Time) Main Effect (Obesity) Interaction  
(Time x BMI) 
      
Measure M (SD) M (SD) F (df) p ηp2 F (df) p F (df) p 
 
Pain 6.35 (1.47) 5.58 (1.63) 51.42 (1,219) <.001 0.19 0.53 (1,219) 0.94 0.05 (1,219) 0.81 
BDI 21.49(11.07) 14.00 (10.03) 124.72 (1,219) <.001 0.36 0.53 (1,219) 0.47 1.09 (1,219) 0.30 
PASS 45.30(25.13) 33.94 (24.98) 55.14 (1,219) <.001 0.20 1.46 (1,219) 0.23 1.08 (1,219) 0.30 
PSEQ 25.14(10.99) 36.82 (12.60) 203.56 (1,219) <.001 0.48 0.001 (1,219) 0.98 0.27 (1,219) 0.61 
PDQ 98.46(18.82) 84.93 (24.35) 31.34 (1,52) <.001 0.38 0.01 (1,52) 0.92 0.53 (1,52) 0.47 
 
 
+ Mixed model ANOVA 
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Discussion 
This study sought to examine whether obesity moderated treatment outcomes from a 
multidisciplinary chronic pain management (MCPM) program. It had previously been shown that 
obesity predicted treatment outcomes in a cognitive behavioral chronic pain treatment program 
such that participants with a body mass index (BMI) over 30 did not show improvement 
comparable with non-obese participants following treatment (Sellinger et al., 2010). By 
examining pre- and post-treatment outcomes on measures of pain intensity, emotional 
functioning, ability to self-manage pain, and perceived disability, this study would show if 
obesity interacted with multidisciplinary treatment in such a way that differential outcomes were 
observed based on a patient’s BMI.  
Results supported the hypothesis that, overall, participants would show significant 
improvements on measures of pain intensity, depression, anxiety, self-efficacy, and perceived 
disability following a 20-day MCPM program. Repeated measures ANOVA showed main effects 
for time on all outcomes, indicating that the MCPM interventions were effective. However, the 
findings of this study do not support the hypothesis that treatment outcomes would vary 
according to weather a participant met criteria for obesity or not. More specifically, it appears 
that obesity did not moderate MCPM treatment outcomes, and obese individuals with chronic 
pain benefitted from MCPM to the same degree as non-obese individuals on all outcomes. There 
was no support found for the hypothesis that obesity would predict treatment dropout. Likewise, 
there was no support found for the hypothesis that obese participants would score significantly 
worse than non-obese participants on measures of pain intensity, depression, anxiety, self-
efficacy, and disability.  As there were no significant differences found between obese and non-
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obese groups on any measures, these findings suggest that obese participants are able to benefit 
from MCPM to the same degree as non-obese participants.  
It was expected that, consistent with other studies reporting patient BMI (Okifuji et al., 
2009; Sellinger et al., 2010; Vincent et al., 2011), obese participants would make up a sizable 
proportion of the sample of chronic pain patients. Not only did obese (BMI ≥30) participants 
comprise 45% of the total sample (compared with a 35% US adult average), but healthy weight 
(BMI≤ 24.9) participants made up only 22% of the total sample, in nearly the same proportion 
(21%) as severely obese (BMI ≥35) participants. Over 78% over the total sample was overweight 
or obese, compared with the US adult average of 69% (Flegal et al., 2012). Whether this larger 
proportion is representative of the chronic pain population is unknown as participant BMI is 
rarely reported in chronic pain literature,  however it is similar to the few previous studies that 
have examined the relationship between chronic pain and obesity.  This high rate provides 
additional support for the growing evidence (Fabricatore & Wadden, 2006; Vaidya, 2006; 
Wright et al., 2010) of the comorbidity of chronic pain and obesity, and it is likely such 
percentages are not unusual. The implication is that any possible impact of obesity on chronic 
pain treatment outcomes could be present for a significant percentage of patients.   
Due to the wide range of negative impacts that obesity poses to physical and emotional 
health (Fabricatore & Wadden, 2006) and consistent with the literature showing greater disability 
related to comorbid obesity and pain (Doll et al., 2000; Yancy et al., 2002), it was hypothesized 
that obese patients would present with greater symptom severity than non-obese patients. 
Furthermore, due to neuroendrocrine changes associated with obesity in fibromyalgia patients 
(Okifuji, 2009) it was considered that a high BMI would function similarly to maintain 
inflammation and therefore, pain intensity. It was also believed that cardiovascular and muscular 
deconditioning would prevent obese participant from engaging fully and benefitting from the 
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exercise and flexibility components of treatment (Rakel & Barr, 2003). Thus, there were several 
possible paths that might block obese participants from benefitting from treatment to the same 
degree as non-obese participants. 
As expected, this sample of patients reported a wide range of negative biopsychosocial 
sequelae related to the impact of chronic pain on their health and quality of life beyond that of 
pain intensity, regardless of their weight status.  Consistent with results reported in previous 
studies (Kerns & Haythornwaite,1988; McCracken & Turk, 2002; Sellinger et al., 2010), these 
patients experienced significant disruption and distress in numerous domains, including 
moderate to severe depression, anxiety, and disability. At intake, 70% of patients reported a 
profound lack of ability to self-manage their pain or engage in valued activities despite their pain 
(PSEQ < 30). Unexpectedly, obese and non-obese participants reported similar amounts of 
dysfunction at intake and discharge, suggesting that the obese participants were not 
disproportionately burdened due to the added stressor of weight. It seemed possible that the 
severity in presentation of the overall sample of participants, comprised mainly of workers’ 
compensation patients, was increased to the degree that healthy weight participants appeared 
similarly dysfunctional to obese participants and were more severely impaired than the 
participants in the Sellinger et al. study. However, a comparison between this study’s non-obese 
participants’ pre-treatment mean BDI scores versus the non-obese participants’ pre-treatment 
mean BDI scores reported by Sellinger et al. found no significant differences (p = 0.38).  
Notably, there was a wide variance in treatment response, with some patients reporting 
changes of over two standard deviations on some measures from pre to post-treatment while a 
significant number of participants reported little to no change on each of the measures.  While 
there was a significant change in pain intensity from pre- to post- treatment (p < .001), the mean 
change in pain rating was less than one point and the modal change was 0.While the effect size 
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of variance explained was large, there was little clinically meaningful change in pain intensity, 
with nearly 60% of participants reporting changes of one point or less. Patients have rated 
reduction in pain as the most important aspect of treatment for them and identify a minimum of 3 
points as meaningful change (Dworkin et al., 2008). Overall, less than 25% of participants 
experienced pain reductions of 2 points or more, and 50% of participants continued to experience 
average pain of 6/10 or higher following treatment. These results are consistent with literature 
showing that there is often little dramatic change in pain intensity associated with MCPM as the 
focus is upon functional restoration and improved quality of life despite pain rather than 
elimination of pain; thus dramatic reductions in pain are neither the intent nor expected outcome 
of treatment (Gatchel & Okifuji, 2006).  
It was expected, however, that obese participants would experience more severe pain at 
treatment intake and discharge based on a previous finding showing a positive correlation 
between BMI and level of pain in persons with chronic pain (Wood et al., 2001). Thus it was 
expected that higher rates of pain and less responsiveness to pain treatment would be reflected in 
highly maintained NRS scores for obese patients. As noted, the entire sample maintained high 
pain intensity ratings following treatment. Possible explanation for the lack of differences in pain 
intensity between obese and non-obese participants may be related to the biases in referral to 
treatment and sample characteristics. A previous study has shown that there is a negative 
relationship between receiving worker’s compensation benefits and treatment outcomes (Burns 
et al., 1995) and that patients who are able to identify a specific trauma responsible for their pain 
report greater pain intensity, emotional distress, and disability (Turk & Okifuji, 1998). This 
particular sample was comprised almost entirely of worker’s compensation patients (95%), many 
of whom had been severely injured in industrial accidents.  It is possible that the intensity of pain 
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and disability in this treatment group is more severe and resistant to treatment overall than other 
chronic pain populations.  
A majority (55%) of patients presented themselves with moderate to severe symptoms of 
depression at intake.  As depression is a frequent comorbidity with chronic pain, this high 
percentage of participants is consistent with the literature and thus rightly targeted by MCPM. A 
significant portion of patients saw a dramatic drop in depression ratings, with 65% reporting a 
change of 5 points or more.  The remainder of patients, however, saw little to no change in their 
depression ratings. These patients typically had mild to low-moderate scores on the BDI at 
intake, and their lack of change likely reflects a “floor” associated with symptoms associated 
with continuing high levels of pain. Some patients, however reported an increase in their rates of 
depression. These increases may have been associated with extraneous circumstances outside of 
treatment, but consistent with the literature (Gatchel et al., 2007), may be related to patients’ 
unhappiness related to the realization of the chronicity of their pain following treatment. 
Furthermore, many patients engaged in worker’s compensation rehabilitation programs are faced 
with difficult life circumstances upon treatment completion as they continued to face 
unemployment, the closure of their worker’s compensation claim, an uncertain future with 
regards to their occupation and career, and continuing difficulties with spouses, families, and 
employers (Burns et al., 1995).  It may be there is also a certain “floor” to the reduction in BDI 
scores in such circumstances.   
Pain related anxiety was measured by the Pain Anxiety Symptoms Scale, a well-validated 
measure that captures the catastrophization and fear-avoidance behaviors that characterize many 
chronic pain patients. As fear-avoidance behaviors have been found to also additionally impact 
obese individuals with chronic pain, presenting a barrier to physical activity, it was considered 
that obese patients with pain would have greater difficulty engaging with the physical modalities 
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of MCPM, including exercise, flexibility, and behavioral activation. Overall patients scored in 
approximately the 45th percentile range of PASS scores, indicating that fear-avoidance and 
catastrophizing cognitions played a low to moderate role participants’ pain. Nearly 50% of 
patients reduced their scores by 10 percentile points or more, indicating a robust response to 
treatment.   
On the PSEQ, scores of 30 or below are associated with low probability of benefitting 
from treatment and maintaining treatment gains, and greater likelihood of ongoing disability; 
scores of 40 or higher are associated with greater benefit from treatment and maintained 
treatment gains at 6-12 months. As noted, following treatment there was a significant increase 
(from 10% to 44%) in the percentage of participants scoring greater than the cutoff of 40/60 on 
the PSEQ, a measure of an individual’s self-efficacy in their ability to engage in valued 
behaviors in spite of ongoing pain.  Scores above 40 have been associated with maintained 
treatment gains at 6-12 months (Nicholas, 2007). Despite a very large effect size (ηp2 = .48), 
indicating that treatment accounted for 48% of the variability in scores (Nandy, 2012), a 
significant percentage of participants showed little change on this measure, with nearly 35% 
reporting changes of 5 points or less. Again it is possible that the heavily skewed sample of 
worker’s compensation patients may provide explanation for the lack of response.  
Perceived disability was evaluated with the Pain Disability Questionnaire (PDQ), 
although this was only given to a small subset of patients  (n = 54) towards the end of the 
sampling period. This measure provided a great deal of useful, possibly predictive information 
that is valuable particularly in light of the lack of physical outcome measures included within 
this study. Relapse is a common problem in chronic pain treatment (Turk & Burwinkle, 2005) 
and the PDQ, perhaps more than any other measure, has been shown to be highly correlated with 
return to work, stay at work, and healthcare utilization rates at one year (Gatchel et al., 2006). 
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This outcome is highly important to the third party referral sources (worker’s compensation) 
whose primary goal is to see their patients return to work.  Furthermore, with treatment scores 
correlated with patient outcomes at one year, the PDQ may be useful for consideration in this 
data set, which is lacking in follow-up measures with participants.  
While the mean reduction in PDQ rating was approximately 13 points, changes ranged 
from a decrease of 61 points to an increase of 23 points. However, as with many other measures, 
the modal change was 0. When PDQ scores were partitioned into previously determined 
theoretical categories (Gatchel et al., 2006), the number of participants scoring in the Extreme 
disability range was reduced by approximately 20% following treatment. Overall, however, 
approximately 70% of participants remained in the Severe or Extreme disability categories at 
discharge suggesting a significant majority of participants continued to view their pain as 
presenting a significant negative impact on their ability to function in everyday life.  
It was expected that obese participants would show differential treatment outcomes when 
compared with non-obese participants as greater rates of self-report disability have been reported 
in obese patients with chronic pain when compared with non-obese (Vincent et al., 2011).  As 
the PDQ captures patients’ perceptions around their ability to engage in activities of daily living 
and physical activity, it provided this study with possible indicator of (subjectively reported) 
physical outcomes, which may be more reactive to obesity based on previous results primarily 
found on self reported physical health measures (Sellinger et al., 2010).  However, there was no 
differential treatment response by obese participants. The lack of an interaction effect on this 
particular measure may indicate that obese participants benefitted from MCPM similarly to non-
obese participants on measures of physical health, which appears to contradict previous findings 
by Sellinger et al. 
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In this study, obese participants showed similar improvements on measures of depression 
(BDI), pain related fear and anxiety (PASS), pain intensity (NRS), ability to self-manage pain 
(PSEQ), and perceived disability (PDQ) as healthy weight individuals. Though these findings 
appear to conflict with a previous study showing that obese participants did not benefit as much 
as non-obese subjects from cognitive behavioral treatment for chronic pain, the absence of 
significant differences on measures of emotional functioning may be consistent with previous 
findings by Sellinger et al. (2010) and Doll et al. (2000), both of whom found significant 
differences on the physical measures of the SF-36 subscales, but not the emotional subscales. 
However, in the previous study, the BDI was used as an additional measure of emotional 
functioning and did show differential treatment outcomes unlike this study. While this limitation 
might have been predictable based on these previous findings, it was considered likely that the 
BDI, PASS, and PSEQ were more extensive instruments that captured a more complete picture 
of each construct, and thus might be more sensitive to differential treatment outcomes. 
Nevertheless, in a sample of chronic pain patients that completed a 20-day MCPM program, 
there were significant improvements seen in five different outcome variables, and most 
importantly, these improvements were seen regardless of obesity. 
Limitations to Study and Suggestions for Future Research   
There were several limitations to this study. Though the overall results of this program 
were positive, as the treatment components were not precisely defined nor uniformly 
implemented, it is impossible to ascertain the mechanism of change, the essential components, or 
how the treatment was conducted. Furthermore, there were no control group data with which to 
compare treatment outcomes. Thus, the internal and external validity are questionable and 
generalizing the results of this program to other MCPM programs is unwise (e.g., Turk, Rudy, & 
Sorkin, 1993).  Furthermore, a significant aspect in chronic pain treatment is also relapse. There 
EFFECTS OF OBESITY ON CHRONIC PAIN TREATMENT  
 
112
were not complete data for follow up evaluations with patients, and the rate of attrition from 
follow-up is typically quite high.  Participant loss to follow-up remains a difficult barrier to 
assessing treatment outcomes (particularly with treatment drop-outs or those who were 
disappointed with their treatment outcomes), but remains an essential aspect of measuring the 
benefits of MCPM. 
Also, previous studies have provided evidence of patient subgroups showing differential 
treatment outcomes. As this particular pain program does not subgroup patients, nor provide 
assessment measures that could make possible a post-hoc subgrouping, it is possible that 
uncontrolled patient heterogeneity contributed to the wide variance in group outcome means, 
reducing the ability of obesity to discriminate between treatment outcomes. Furthermore, 
treatment outcomes are the result of the interaction between a multitude factors, so a single 
factor such as obesity may not explain a great deal of the variance in outcome. However, it 
should previously be noted that in the study previously documenting differentiated treatment 
effects (Sellinger et al., 2010) there were no treatment outcome differences found on pain 
intensity scores (NRS) or the Mental Component score of the SF-36V, in which scores also 
remained relatively static from pre- to post-treatment.  With the exception of the PDQ, the 
measures evaluated on this study were limited to pain intensity, and self-report psychosocial 
functioning measures, similar to measures on the previous study that were not differentially 
affected by obesity. While the PDQ does capture outcomes related to physical experience, they 
are not entirely comparable with the physical component, physical function, physical role, 
bodily pain, and vitality scores of the SF-36, areas previously found to indicate differentiated 
treatment outcomes for obese patients. It is possible that the domain of experience captured in 
this previous study was not adequately captured by the measures employed by this pain 
management clinic 
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A significant critique of MCPM is the lack of presumed treatment fidelity, as it is 
unknown the extent to which treatment is conducted in a specified and consistent manner (Turk, 
Rudy, & Sorkin, 1993).  With the variance seen in mechanism of injury, degree of disability, and 
degree of psychopathology seen at intake, it can be difficult to state that patients received 
uniform treatments, to specify the exact treatment process, or to what comprised the effective 
components of treatment.  Future studies looking at this population will benefit from including a 
reliable source of objective physical treatment outcome measures related to functional 
improvement, such as measures of physical endurance and physical health quality of life. It 
would also be important to gather more sensitive and specific measures of response to treatment 
rather than “improved/not improved endurance.” The lack of findings may also be related to the 
focus on psychological self-reports measures, despite the wide range of behaviors and 
experiences encompassed. It is possible that if there had been appropriate objective physical and 
self-report physical-health measures, a differential response to treatment may have been detected 
in these domains. 
An important aspect to bear in mind is the fact that workers’ compensation patients are 
required to attend treatment by their claims adjuster or risk losing their benefits. It is often 
believed that many of workers’ compensation patients (Burns et al., 1995) are not necessarily 
motivated to perform at the best of their abilities as this could have a negative impact on any 
eventual disability amount they are awarded.  Considering the number of patients that showed 
little to no change on psychosocial measures related to treatment, it may be worth considering 
whether this particular patient population was consistently highly motivated to engage in a 
highly physical and intensive treatment that required attendance away from home for 20 days, 
did not focus upon a reduction in pain, and often required participants to reduce or eliminate 
their current medications. Moreover, as noted, many of these workers’ compensation patients 
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consider themselves to be at “treatment of last resort” before being declared maximally 
medically improved, so the amount of clinically significant change may be influenced by this 
factor.  
In considering the applicability of these results to other chronic pain treatment programs, 
it is noted that this study consisted of a heavily skewed convenience sample (95%)  of 
participants referred by worker’s compensation programs. These patients are often “at the end of 
the line” of treatment options and likely not representative of chronic pain patients in general. 
Furthermore, there were few exclusion criteria to the program, thus the participants are a 
heterogeneous sample with numerous mechanisms of injury including headache, crush injuries, 
musculoskeletal injury and degeneration, CNS/spinal injury, peripheral neuropathy, arthritis, 
lower extremity injury, upper extremity injury, etc. Additionally, the sample consisted of a wide 
range of ages, severity of pain, degree of emotional distress, and disability.  Based on these 
characteristics, it is unlikely that the results could be generalized to other MCPM management 
programs.  
As noted, a significant proportion of patients showed little change on outcome measures 
(although obesity did not seem to be a significant factor to this), which appears consistent with 
literature on treatment outcomes with workers’ compensation patients (Burns et al., 1995). As 
additional research continues to explore the mechanisms of action within MCPM, findings may 
be able to determine if there are particular treatment components within the program that 
addressed possible limitation posed by obesity that therefore made it possible for patients to 
benefit in similar ways. Further analysis should investigate the factors that contribute the most to 
overall treatment outcome variance to determine if any differences on baseline and patient 
characteristics can be found that predict the greatest degree of improvement.  Lastly, this 
particular MCPM program might benefit from employing the SF-36 as outcome measure due to 
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this measure’s frequent use by other chronic pain research programs, thus facilitating 
comparisons of treatment outcomes in the future.  
In summary, the findings from this dissertation indicate that obese and non-obese chronic 
pain patients experience similar levels of disability and distress in multiple pain-related domains, 
and show a similar positive response to MCPM. These equivalent responses were found in the 
domains of pain intensity, depression, fear and anxiety, self-efficacy, and perceived disability, 
domains that have been previously shown to also be negatively impacted by obesity. The 
literature makes clear that the comorbidity of obesity and chronic pain not only serve to 
exacerbate one another, but may, in some instances, present a barrier to treatment. For instance, 
it has been suggested that obesity may interfere with the physical modalities of chronic pain 
treatment, including exercise, flexibility, and behavioral activation (Rakel & Barr,  2003). A 
previous finding (Sellinger et al, 2010) suggested that obese participants showed less 
improvement on depression scores and measures of physical health quality of life following CBT 
for chronic pain. While countless previous studies have examined the role of patient 
characteristics in chronic pain treatment outcomes, few had explored the role of obesity despite 
the conditions’ common comorbidity. This study addressed this gap in the literature by 
examining the role of obesity in treatment outcomes of a multidisciplinary chronic pain 
management (MCPM) program. 
While the undifferentiated response to treatment failed to support the proposed 
hypotheses, it appears that obese participants, even those with BMIs over 40, are able to benefit 
significantly from MCPM programs.  As chronic pain has been shown to present a significant 
barrier to weight-loss treatment (Mauro et al., 2008; Okifuji et al., 2010), it may be worth in the 
future investigating whether providing MCPM to obese individuals prior to or concurrent with 
weight loss treatment would improve engagement and outcomes. Although the relationship 
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between the experience and treatment of comorbid chronic pain and obesity have not been made 
fully explicit, it has been proposed that obese patients respond to chronic pain in ways that 
promote or aggravate their obesity, such as engaging in less activity and increased hedonic 
eating. It is believed that these behaviors are mediated by an increased fear of movement, less 
self-efficacy for activity, and a greater perception of disability (Vincent et al, 2011). Many of 
these factors contribute substantially to the development and maintenance of chronic pain and 
are targeted specifically by MCPM.  As this barrier has been identified, it seems that the results 
of this study indicate that there are possible ways to increase patient success by incorporating 
MCPM prior to obesity treatment, as has been encouraged by previous studies in both chronic 
pain and obesity treatment (Mauro et al., 2008; Sellinger et al., 2011). By addressing this 
comorbidity directly, not only would physical factors be better addressed, but improvements in 
emotional functioning, self-efficacy, fear avoidance, and perceived disability could increase 
patients’ long term success.  Lastly, due to the high prevalence of overweight and obesity within 
chronic pain populations, the field may benefit from additional qualitative information gathered 
from obese patients so we might better understand the impact of comorbid pain and obesity upon 
their lives. 
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